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PROMOTER ELEMENTS ANALYSIS OF KATANIN P80 GENE 
SUMMARY 
Katanin is a heterodimeric protein that severes microtubules by hydrolyzing ATP. 
Katanin consists of 60 kDa and 80 kDa polypeptides. 60 kDa subunit (p60) coded 
from KATNA1 gene, has the enzymatic activity to break microtubules, whereas 80 
kDa subunit (p80) coded from KATNB1 gene, has a role in localization of the protein 
complex in the cell. Katanin has been shown to have roles for microtubule severing in 
mitotic cells including release of microtubules from centrosome, depolymerization of 
microtubule minus ends in the mitotic spindle. 
In this study, characterization of  promoter site of KATNB1 and its potential effect 
on katanin gene expression regulation are aimed to be revealed. Identification of 
transcription factor binding sites in the promoter of the KATNB1 gene is in a great 
importance to understand temporal gene expression pattern of katanin which slightly 
differs between different stages of development. Identification of this gene regulation 
pattern will be a pioneer study for understanding the gene expression regulation of 
KATNB1 gene. 
In this study, we set out sight on the identification of transcription factor binding sites 
(cis-regulatory elements) of KATNB1 promoter. By using this information, it will be 
possible to study the genetic and/or epigenetic factors which may be related with the 
cell division. 
For characterization of promoter of KATNB1 gene, polymerase chain reaction (PCR) 
is used to amplify 1000 bp upstream nucleotides of KATNB1 gene. By using internal 
primers and nested PCR technique, shorter fragments are obtained. These promoter 
deletion constructs are cloned into a luciferase reporter plasmid vector which lack 
eukaryotic promoter and enhancer sequences. We took advantage of luciferase assay 
system for functional analysis of the promoter by transfecting neuroblastoma cells 
with these constructs and the effects of promoter parts on katanin expression is 
examined. 518 bp TATA-less promoter was found to be sufficient for high levels of 
activity. The luciferase reporter assay in human neuroblastoma cells indicated 
repression of promoter activity in the presence of overexpressed Elk-1 transcription 
factor and the assay also showed that overexpresion of PEA3 transcription factor had 
no effect on KATNB1 promoter activity. 
 
 
 
 
 
 
 
 xx
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KATANĐN P80 GENĐNĐN PROMOTOR ELEMENTLERĐNĐN ANALĐZĐ 
ÖZET 
Katanin 60 kDa (p60) ve 80 kDa (p80) büyüklüğünde iki alt üniteden oluşan ve ATP 
hidrolizleyerek mikrotubulleri parçalayan bir proteindir. KATNA1 geni tarafından 
kodlanan p60 alt ünitesi enzim aktivitesi ile mikrotubulleri keserken, KATNB1 geni 
tarafından kodlanan p80 alt ünitesi enzimin hücre içindeki lokalizasyonunda 
görevlidir. Mitotik hücrelerde kataninin mikrotubullerin sentrozomdan kesilerek 
serbest bırakılması, mikrotubul eksi uçlarının depolimerize edilmesiyle mitoz 
esnasında kromozomların kutuplara çekilmesi gibi hücre içi olaylarda görevli olduğu 
düşünülmektedir. 
Bu çalışma ile KATNB1 geninin promotorundaki nükleotid dizisinin 
karakterizasyonunu ve bu dizinin katanin gen ifadesinin regülasyonu üzerine olan 
etkilerini ortaya çıkarmak amaçlanmıştır. Promotor bölgesindeki transkripsiyon faktör 
bağlanma bölgelerinin aydınlatılması kataninin gelişim süreci boyunca 
ekspresyonunun regülasyonunu anlamak açısından da büyük öneme sahiptir.  Elde 
edilecek bu bilgi kullanılarak katanin gen ifadelenmesi üzerine etkisi olan diğer bazı 
genetik ve/veya epigenetik etkilerin aydınlatılması mümkün olabilecektir.  
Çalışmada promotor bölgesinin karakterizasyonu için polimeraz zincir reaksiyonu 
(PZR) ile KATNB1 geninin 1000 baz öncesinden başlanarak delesyon konstraktları 
hazırlanmış ve uygun primerler ile nested PZR tekniği uygulanarak daha kısa parçalar 
elde edilmiştir. Bu diziler promotor içermeyen fakat raportör (bildirici) bir gen 
(lusiferaz) içeren bir plazmit vektöre klonlanmıştır. Promotor bölgenin fonksiyonel 
analizi için bu konstraktların insan nöroblastoma hücrelerine transferiyle gen 
ekspresyonu üzerindeki etkilerinin incelenmesinde lusiferaz enziminin katalitik 
aktivitesinden yararlandık. Bu yolla katanin ekspresyonu üzerinde kilit öneme sahip 
nükleotid dizilerini bulunmuştur. 518 bp’lik TATA-sız promotorun yüksek seviyede 
promotor aktivitesi için yeterli olduğu gösterilmiştir.  Lusiferaz bildirici deneyi ile 
insan nöroblastoma hücrelerinde, promotor bölgenin Elk-1 transkripsiyon faktörü 
tarafından baskılandığı, PEA3 transkripsiyon faktörünün ise KATNB1 promotor 
bölgesi üzerinde etkisinin olmadığı gösterilmiştir. 
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1.  INTRODUCTION 
1.1 Microtubules 
Microtubules are polar linear polymers that perform major organizational tasks in 
living cells. Through a unique feature of microtubule assembly, termed dynamic 
instability, they function as molecular machines that move cellular structures during 
processes. They are also involved in generation of cell morphogenesis and 
organization, cell division, cell growth and intracellular organelle transport (Antal et 
al., 2007).  
Microtubules are thought to have the most important roles among cytoskeletal fibers 
which are separated into 3 groups; intermediate filaments, microfilaments and 
microtubules. There are three distinct steps in the life cycle of a microtubule, namely, 
nucleation, assembly and disassembly. A microtubule nucleates, assembles by 
addition of subunits to its growing ends, and disassembles by endwise loss of 
grouped subunits (Wade and Hyman, 1997) 
Microtubules are composed of a protein called tubulin, which is a heterodimer 
composed of related α and β chains. Those monomers are proteins of about 450 
amino acids each and are about 50% identical at the amino acid level. Each monomer 
has a molecular mass of about 50 kDa (Burns, 1991). Each tubulin heterodimers 
form extended asymmetric protofilaments. Each tubulin heterodimer is located in the 
same orientation within the protofilament. Thirteen different protofilaments associate 
to form a cylindrical microtubule 25 nm in diameter, and all of the protofilaments are 
aligned as parallel (Watson et al., 2004). The crystal structure of the tubulin 
monomer (a) and the tubulin protofilament (b) can be seen in figure 1.1. The α 
subunit is shown in turquoise and the β subunit is shown in purple.  
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Figure 1.1 : Structures of the tubulin monomer and filament (Watson et al., 2004). 
Each monomer binds a GTP molecule, nonexchangeable in α-tubulin and 
exchangeable in β-tubulin. GTP from β-tubulin is required for microtubule assembly, 
and its hydrolysis follows addition of a dimer to the microtubule end, upon which it 
becomes nonexchangeable within the microtubule. Microtubules comprising GTP-
bound tubulin at the plus end are stable since these GTP caps strengthening the 
lattice of microtubule. Therefore, microtubules with tubulin-GTP continue to 
elongate (Caplow and Shanks, 1996). This phase is known as microtubule growth 
phase. As soon as the GTP cap of microtubule is detached, the lattice of microtubule 
becomes unstable and protofilaments are peeled from the lattice (Desai and 
Mitchison, 1997). This phase is known as shrinkage. Microtubules are switching 
between growth and shrinkage phases. This feature is entitled as dynamic instability 
(Mitchison and Kirschner, 1984) illustrated in figure 1.2. 
 
Figure 1.2 : Illustration of dynamic instability (Wiese and Zheng, 2006). 
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The structures of α- and β-tubulin are basically identical: each monomer is formed by 
a core of two β-sheets surrounded by α-helices. The monomer structure is very 
compact, but can be divided into three functional domains: the amino-terminal 
domain containing the nucleotide-binding region, an intermediate domain containing 
the taxol-binding site, and the carboxy-terminal domain, which constitutes the 
binding surface for motor proteins (Nogales et al., 1998). There are two proposed 
models for microtubule nucleation from tubulin dimers to microtubules shown in 
figure 1.3. In the first model (a) tubulin dimers associate to form sheets which 
subsequently close into microtubules. The second model (b) suggests that tubulin 
molecules associate to form oligomers that subsequently combine to form sheets and 
microtubules (Valiron et al., 2001). 
 
Figure 1.3 : Microtubule nucleation models (Valiron et al., 2001). 
There are both lateral and longitudinal interactions between the tubulin heterodimer 
subunits and these interactions maintain the tubular form of microtubules. Thus, 
there is an intrinsic polarity in microtubules. One end of the microtubule is called the 
rapidly growing plus end, while the other end is called the minus end and it is more 
stable. Although microtubule polarity was originally defined in terms of the 
preferential addition of tubulin subunits onto the plus end of the polymer, it is now 
apparent that the polarity of the microtubule is also relevant to its transport properties 
(Baas, 1999). In addition to α - and β - tubulins, there is a special third type of 
tubulin named γ -tubulin. It is located in the centrosomal matrix, which is the 
primary site for microtubule nucleation in animal cells. γ-Tubulin, is related to α/β-
tubulin and it is required for initiating the polymerization of microtubules in vivo. γ-
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Tubulin has been found in two main protein complexes: the γ-tubulin ring complex 
and its subunit, the γ-tubulin small complex. Microtubules are thought to be 
nucleated from γ -tubulin ring complexes (γ -TuRCs) and these microtubules 
nucleated from γ -TuRCs have minus ends that are physically capped. These caps 
prevent minus-end polymerization and depolymerization (Moritz and Agard, 2001). 
 
Figure 1.4 : Polymerization of tubulin nucleated by γ-tubulin ring complex                                      
(Moritz and Agard, 2001). 
The intrinsic microtubule dynamics are further modified in the cell by interaction 
with cellular factors that stabilize or destabilize microtubules, which operate in both 
spatially and temporally specific ways to generate different microtubule assemblies 
during the cell cycle. Microtubule stability is promoted to a large degree by 
microtubule-associated proteins (MAPs). Classical MAPs, such as MAP2 and Tau, 
bind to the surface of the microtubule, bridging several tubulin subunits and possibly 
neutralizing the repulsive negative charge on the microtubule surface (Heald and 
Nogales, 2002). 
Microtubules serve extensively important functions in some specialized cells like 
neurons. Microtubules in neurons which are post-mitotic cells are not employed for 
spindle formation but rather they function in elongation of axons (Karabay et al., 
2004). Crucial events for axonal differentiation such as elongation, branching, 
navigation, retraction, are accomplished by changes in the configuration and 
behavior of microtubules (Baas and Buster, 2004). Microtubules are essential for 
axonal growth, and yet axons are incapable of locally synthesizing the tubulin 
subunits that compose microtubules. For this reason, tubulin must be actively 
transported down the axon from its site of synthesis within the cell body of the 
neuron (Baas, 1997). 
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1.2 Microtubule Severing 
Although the dynamic behavior of the microtubules results primarily from the 
regulation of the subunit exchange at the ends of the microtubule polymer other 
mechanisms are important as well (Karabay et al., 2004). It has been shown that 
forces generated by motor proteins are essential for transporting microtubules into 
the axon, and potentially for integrating microtubules with neighboring microtubules 
and other cytoskeletal elements in neurons. (Ahmad et al., 1998). 
Other data strongly suggest that the capacity of a microtubule to move in response to 
these forces is inversely proportional to the length of the microtubule, shorter the 
microtubule more rapid is the movement (Dent et al., 1999). Thus, it is obviously 
clear that microtubule movement may be regulated by regulation of its length. The 
physical length of these complexes being regulated by two different mechanism: (a) 
addition/loss of tubulin subunits at the ends of the microtubule polymer; and (b) 
internal breakage of the polymer by microtubule severing enzymes. This process, 
which can generate shorter microtubules from longer ones is known as microtubule 
severing (Casanova et al., 2009).  
According to the proposed ‘cut and run’ model for microtubule transport, the motor 
proteins bind to all microtubules, regardless of their length, but cannot transport the 
longer microtubules, due to obstacle imposed on the microtubules as a result of 
crosslinks with other structures. The long immobile microtubules can only be 
transported after being severed into shorter pieces (Baas et al., 2005).  
The first report of biochemical microtubule severing activity came from observations 
using Xenopus oocyte. A protein component of mitotic oocyte extracts caused the 
stable microtubules to be fragmented into numerous short segments. It was reported 
that the severing activity was low in interphase and was activated during mitosis 
through a posttranslational mechanism and suggested that microtubule severing may 
complement subunit exchange at the ends of microtubules in disassembling the 
interphase microtubule network at the onset of mitosis (Vale, 1991).  
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Three MT-severing enzymes have so far been identified: katanin, spastin and 
fidgetin, all belonging to the AAA (ATPases Associated with diverse cellular 
Activities) family of ATPases. These relatively recently discovered proteins play 
critical roles in essential cell processes such as mitosis, neuronal development and 
function, axonal branch formation and cilia biogenesis, and, as such, can be the cause 
of major human diseases (Casanova et al., 2009).  
When it comes to possible roles of microtubule severing, there are many different 
mechanism involved in a wide range of research with different organisms. These 
three different microtubule severing enzymes, spastin, fidgetin, and katanin are 
shown to contribute to the “Pacman-flux” machinery that moves chromosomes in 
Drosophila melanogaster (Zhang et al., 2007). Data from a study about 
Chlamydomonas deflagellation suggest that a katanin-like mechanism may mediate 
the severing of the outer doublet microtubules during deflagellation (Lohret et al., 
1998). In another study, PF15p, which is the Chlamydomonas homologue of the 
katanin p80 subunit is shown to be required for assembly of flagellar central 
microtubules (Dymek et al., 2004). A very recent work on Chlamydomonas affirmed 
that katanin severs doublet microtubules at the proximal end of the flagellar 
transition zone, allowing disengagement of the basal body from the flagellum before 
mitosis (Rasi et al., 2009). A study conducted on Caenorhabditis elegans showed 
that MEI-1/MEI-2 katanin-like microtubule severing activity is required for C. 
elegans meiosis (Srayko et al., 2000) and further studies proved that MEI-1/katanin 
is required for translocation of the meiosis I spindle to the oocyte cortex (Yang et al., 
2003). A recent study about prostate cancer declared that LAPSER1, a putative 
cytokinetic tumor suppressor showed the same centrosome and midbody subcellular 
localization pattern as p80 katanin subunit (Sudo and Maru, 2007) and another study 
showed that LAPSER1/LZTS2 a pluripotent tumor suppressor was linked to the 
inhibition of katanin-mediated microtubule severing, indicating that microtubule 
severing at centrosomes is a novel tumor-associated molecular subcircuit in cells, in 
which LAPSER1 is a regulator (Sudo and Maru, 2008, Maru, 2009). In another 
work, microtubule-severing proteins are shown to be involved in flagellar length 
control and mitosis in Trypanosomatids (Casanova et al., 2009). In Tetrahymena, 
katanin activity is shown to be essential and the net effect of katanin on the polymer 
mass depends on the microtubule type and location, it is proposed that katanin 
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mediated severing is non-random in vivo and that its activity is required to inhibit 
accumulation of post-translational modifications o microtubules. It is also postulated 
that katanin preferentially severs older, post-translationally modified segments of 
microtubules (Sharma et al., 2007).  
Microtubule severing also plays a role in specific activities of differentiated cells for 
instance there are a great number of studies about neurons. It has been shown that 
microtubule severing by katanin is essential for releasing microtubules from the 
neuronal centrosome, and also for regulating the length of the microtubules after 
their release (Ahmad et al., 1999). These data support the idea that microtubule 
severing by katanin is important for the production of non-centrosomal microtubules 
in cells such as neurons and epithelial cells (Quarmby, 2000). Axonal growth is 
found to be sensitive to the levels of p60 katanin, the mechanisms that controls 
katanin levels and activity could be key to determining the growth   properties of the 
axon (Karabay et al., 2004). 
1.3 AAA Family Proteins 
AAA ATPases (ATPases Associated with various cellular Activities) play important 
roles in numerous cellular activities including proteolysis, protein folding, membrane 
trafficking, cytoskeletal regulation, organelle biogenesis, DNA replication, 
recombination, restriction, sporulation, chelation, vesicle fusion, and intracellular 
motility. Sequence analysis indicates that this is an ancient class of proteins and the 
utility of these proteins is also evident by their abundant genomic representation 
(Vale, 2000; Neuwald et al., 1999). 
The mutual feature of the AAA superfamily is an ATPase domain. It is known that 
AAA domains assemble into oligomeric structures and this allows proteins to change 
their shapes during ATPase cycle. ATP binding induces structural rearrangements at 
the interface region of AAA proteins. This increases interactions between adjacent 
AAA domains, also increases interactions between AAA protein and its target 
(McNally, F., 2000). The ATPase domains of these proteins assemble into active 
ring-shaped hexamers, this allows subunits to switch between tense and relaxed 
states in a concerted manner. These structures also provide framework for binding 
target proteins at multiple sites. If ring-binding sites change their positions, this will 
also cause tension application to bound protein (Vale, 2000).  
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Figure 1.5: Conformational change of AAA protein ring (Vale, 2000). 
While AAA proteins are highly homologous within the ATPase domain, usually 
located at the C-terminus of the protein, other regions of these proteins typically 
show little sequence similarity. The ATPase domain of AAA proteins is 200–250 
amino acids long and is characterized by a number of domains that are important for 
ATP binding and hydrolysis. These include the Walker A P-loop, Walker B motif, 
sensor-1 and sensor-2 motifs, arginine finger and a second region of homology that 
differentiates classically defined AAA proteins such as NSF from the broader AAA+ 
family that includes members such as dynein. There are two other motifs conserved: 
the N-linker, which may transduce energy from ATP hydrolysis to the rest of the 
protein, and the loops that line the pore of a AAA oligomer (White and Lauring, 
2007).  
Their biological functions can be sub-grouped in three categories. First group is 
composed of  those AAA family members that remodel protein complexes without 
unfolding or destroying their target proteins and the second group, those that are 
involved in protein quality control and do unfold their targets. Finally, a third group 
of microtubule-interacting proteins as their activities are unique in terms of the larger 
AAA family. This third group can be further divided into two sub-categories, motor 
proteins including the most well known cytoplasmic dynein and microtubule 
severing enzymes including katanin, spastin, and fidgetin. Those proteins are 
associated with microtubules in a different way; they are microtubule severing 
enzymes that make internal breaks in microtubules (White and Lauring, 2007). 
Katanin is the most well known microtubule-severing protein which will be 
discussed in detail in the coming section. Spastin is another microtubule-severing 
protein that is mutated in around 40% of cases of autosomal dominant hereditary 
spastic paraplegi (Salinas et al., 2007). Finally, fidgetin is another microtubule-
severing protein, whose gene is found to be mutated in fidget mice. The mutant mice 
have small eyes, associated with cell-cycle delay and insufficient growth of the 
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retinal neural epithelium, and lower penetrance skeletal abnormalities, including 
pelvic girdle dysgenesis, skull bone fusions and polydactyly. Fidgetin is the first 
mutant AAA protein found in a mammalian developmental mutant, thus defining a 
new role for these proteins in embryonic development (Cox et al., 2000). In a recent 
study, spastin and fidgetin have been shown to stimulate microtubule 
depolymerization during anaphase in cultured Drosophila cells (Zang et al., 2007). 
Yet it is unclear how these enzymes use their ATPase activity to sever microtubules. 
1.4 Katanin 
Katanin is the most well characterized microtubule-severing protein. It was first 
appeared in scientific field in 1991, a protein component of mitotic Xenopus oocyte 
extracts caused the stable microtubules to be fragmented into numerous short 
segments (Vale, 1991). After that, a microtubule-severing protein from sea urchin 
eggs was purified and initially characterized. It was named katanin, a word derived 
from katana, which means the samurai sword in Japanese (McNally and Vale, 1993). 
Similar to the severing activity of M-phase Xenopus extracts, katanin requires ATP 
hydrolysis to sever microtubules in vitro (Vale, 1991; McNally and Vale, 1993). 
Video microscopy of the severing reaction showed that katanin rapidly and 
completely disassembled individual microtubules immobilized on the surface of 
glass coverslips only in presence of ATP.  
This protein is a heterodimeric protein consisting of two subunits (McNally and 
Vale, 1993). p60 katanin subunit named after its 60 kDa molecular weight  is coded 
from KATNA1 gene located in the long arm of chromosome 6 (6q25.1)  in Homo 
sapiens (Url-1). The other subunit p80, named after its 80 kDa molecular weight is 
coded from KATNB1 gene located  in the long arm of chromosome 16 (16q13) in 
Homo sapiens (Url-2). 
The subcellular localization of katanin was determined by immunofluorescence in 
sea urchin, it is highly concentrated at centrosomes throughout the cell cycle, in a 
region surrounding the -tubulin containing pericentriolar region (McNally et al., 
1996). The cloning of both katanin subunits from sea urchin and human has revealed 
that the 60 kDa subunit is a member of the AAA family of ATPases (Hartman et al., 
1998; McNally and Thomas, 1998). Its N-terminal domain binds microtubules and 
C-terminal is the AAA domain (McNally K. et al., 2000).  
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Recombinant p60 katanin, expressed in Sf9 cells, has microtubule-severing activity 
and thus, appears to be the catalytic, enzymatic subunit that carries out the ATPase 
and severing reactions. Baculovirus-expressed other subunit p80 has no ATPase or 
severing activity in the absence of p60. This evidence suggests that p80 may be 
responsible for targeting p60 to the centrosome. The fact that p80 is present 
throughout all compartments of the neuron argues that its function can not be solely 
to target katanin to the centrosome. Biochemical studies have established that p80 
katanin consists of multiple domains with different functions. Through deletion 
analysis of p80, a p60 dimerization domain, procon80 in its C-terminal domain and a 
separate centrosome-targeting domain consisting of six WD40 repeats in its N-
terminal domain was mapped. The interaction profile of p60 and p80 katanin can be 
seen in figure 1.6. For p60 katanin, the domain shown in orange is required for 
association with the C-terminal domain of p80, the domain shown in blue is the 
microtubule binding domain and the domain shown in red is the ATPase domain. For 
p80 katanin, the domain shown in bright blue is the N-terminal WD40 domain which 
is required for centrosome or spindle pole targeting, the domain shown in blue is the 
microtubule binding domain and the domain shown in yellow is the procon80 
domain that includes p60 binding domain. 
 
Figure 1.6 : The interaction profile of p60 and p80 katanin, adapted from Sudo and Maru (2008). 
It was also shown that deletion of a 130 amino acid domain at the extreme COOH-
terminus of p80 resulted in the complete inability of protein to dimerize with p60, 
whereas deletion of p80’s amino-terminal WD40 domain had no effect on p60 
dimerization and fusion of the WD40 domain to green fluorescent protein (GFP) 
revealed targeting of the construct to the centrosome in mammalian cells (Hartman et 
al, 1998).  
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The N-terminal WD40 domain of p80 katanin was found to act as a negative 
regulator of microtubule disassembly activity and also required for spindle pole 
localization, possibly through interactions with another spindle-pole protein. Both 
domains of p80 seem to be essential in precisely regulating katanin’s activity in vivo 
(McNally K. et al., 2000). Although p60 shows its ATPase and severing activity in 
the absence of p80 subunit, p80 cannot sever microtubules on its own. Besides 
targeting katanin to the centrosomes, it also enhances severing capacity of p60. 
Association of the two subunits increases their affinity for microtubules and also 
microtubule-severing activity (Hartman et al., 1998). 
Katanin is a microtubule stimulated ATPase; thus microtubule concentration affects 
the enzyme activity. A florescence resonance energy transfer assay demonstrated that 
the p60 subunit of katanin oligomerized in an adenosine triphosphate (ATP) and 
microtubule dependent manner. ATPase activity increases between 2µM-10µM 
microtubule concentrations, but at higher microtubule concentrations (>10µM), 
ATPase activity decreases. This ATPase behavior of katanin is unexpected, not 
matching the Michaelis–Menten hyperbolic stimulation. There are some explanations 
for that situation. Katanin binds microtubules at two sites, this increases local 
microtubule concentration by cross-linking and thereby stimulates katanin’s ATPase 
activity. At higher microtubule concentrations, the ratio of katanin to microtubules is 
lower, less cross-linking occurs, thus less ATPase stimulation will be observed. A 
second explanation is about katanin oligomerization into rings. Microtubules 
promote p60-p60 oligomerization and oligomerization stimulates ATPase activity. 
While low microtubule concentrations facilitate oligomerization because of p60 
monomers being more likely to bind near one another on the microtubule, when the 
microtubule concentration is high, this will inhibit p60 assembly by sequestering p60 
monomers at non-contiguous sites (Hartman and Vale, 1999). Those data suggest a 
model for microtubule severing by katanin. Katanin-ADP is monomeric, but 
nucleotide exchange for ATP enhances p60-p60 affinity making oligomerization the 
most efficient. However, in the presence of its protein substrate, the p60 ring binds to 
microtubules with high affinity and once katanin oligomers assemble on the 
microtubule, ATPase activity is stimulated. Katanin ring conformation could change 
due to nucleotide hydrolysis and subsequent phosphate release that will lead to 
mechanical strain that destabilizes tubulin-tubulin contacts. This leads to the 
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dissociation of complex and the recycling of the katanin (Hartman and Vale, 1999; 
Quarmby, 2000). A model of microtubule severing by katanin is illustrated in figure 
1.7. 
 
Figure 1.7: Model for microtubule severing by katanin (Hartman and Vale, 1999). 
In cells, microtubule severing is controlled by regulatory factors, they can be used to 
hold the severing complex together after ATP hydrolysis, or might protect the new 
plus and minus ends from immediate disassembly just like MAPs. At the spindle 
pole, severing might produce free microtubule ends, allowing for the poleward flux 
of tubulin and poleward movement of the microtubule. At the centrosome, 
microtubule severing might release microtubules. In the cytoplasm, microtubule 
severing might facilitate treadmilling (Quaramby, 2000). Although it is known that 
katanin forms a transient hexamer in the presence of both ATP and microtubules 
(Hartman and Vale, 1999), the microtubule binding site to the hexamer remains to be 
unknown. Possible binding sites include the outside of the microtubule, the MT 
lumen, or the sides of dimers exposed by holes in the lattice; suggesting that katanin 
might act specifically at points in the lattice that contain defects. (McNally F., 2000). 
To interpret the experimental observations, a number of theoretical models were 
developed and compared quantitatively to the experimental data via Monte Carlo 
simulation. Models assuming that katanin acts on a uniform microtubule lattice were 
incompatible with the in vitro data, whereas a model that assumed that katanin acts 
preferentially on spatially infrequent microtubule lattice defects was found to 
correctly predict the experimentally observed breaking rates, number and spatial 
frequency of severing events, final levels of severing, and sensitivity to katanin 
concentration over the range 6–300 nM (Davis et al., 2002). These data are further 
supported by a study conducted on motile cilia Tetrahymena, a cell type with 
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elaborate microtubule arrays. It has been shown that katanin promotes assembly of 
ciliary microtubules, and therefore its effects are microtubule-type specific. Katanin-
mediated severing is nonrandom in vivo and that its activity is required to inhibit 
accumulation of post-translational modifications on microtubules by regulating the 
longevity of nonciliary microtubules by preferentially depolymerizing post-
translationally modified segments of the polymer (Sharma et al., 2007). 
Also, it has been shown that there is an interaction between p60 katanin and P-
NDEL1. This protein NDEL1, participates in the regulation of cytoplasmic dynein 
function during neuronal development. It is found to be mutated in the human 
neuronal migration defect lissencephaly and along with its partner LIS1. Abnormal 
accumulation of p60 in nucleus of Ndel1 null mutants supported an essential role of 
NDEL1 in p60 regulation (Toyo-Oka et al., 2005). It is also known that NDEL1 with 
its binding partner DISC1 and NDE1 is critical to neurodevelopmental processes 
aberrant in schizophrenia and NDEL1 significantly influences risk for schizophrenia 
via an interaction with DISC1 (Burdick et al., 2008). In another genome-wide 
transcriptome analysis study, using the postmortem brains of bipolar disorder 
sufferers and schizophrenic subjects confirmed the differential expressions of eight 
genes in a bipolar-specific manner. Those genes include KATNB1, coding for 
katanin p80 subunit (Nakatani et al., 2006). Taken together those studies indicate a 
novel role for katanin in psychiatric diagnosis like bipolar disorder and 
schizophrenia. 
Although katanin’s regulation and localization suggest a role in mitosis, its presence 
in adult brain tissue implies a second function in nondividing cells. Neurons express 
two different microtubule-severing proteins, namely p60-katanin and spastin. 
Because katanin is found at centrosomes in a variety of species and cell types, it is 
likely that katanin is concentrated around centrosomes in neurons as well. It was 
postulated that katanin concentrated at the centrosomes of neurons could release 
microtubules from their centrosomal attachment sites in the cell body to allow 
transport of microtubules down the axon (Baas and Yu, 1996). Axonal growth was 
found to be influenced of katanin levels, in neuronal cultures, katanin levels are high 
when axons are allowed to grow avidly but drop when the axons are presented with 
target cells that cause them to stop growing. Also expression of a dominant-negative 
p60-katanin construct in cultured neurons inhibits microtubule severing and is found 
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to be deleterious to axonal growth (Karabay et al., 2004). The ratio of p60 to p80 
subunits are shown to vary in different tissues, at different time of development and 
regionally within the neuron. P80 subunit is found to be more concentrated in the cell 
body and less variable during development, whereas p60 is found to be often 
concentrated in the distal tips of processes (Yu et al., 2005). Studies conducted on 
different cell types show that katanin acts on microtubules according to the proposed 
‘cut and run’ model. This activity is extremely important for microtubule 
organization and regulation. Motor proteins bind to all microtubules, regardless of 
their length, but cannot transport the longer microtubules; the long immobile 
microtubules can only be transported after being severed into shorter pieces by (Baas 
et al., 2005). The ‘cut and run’ model is illustrated in figure 1.8. 
 
Figure 1.8: The ‘cut and run’ model for microtubule reconfiguration (Baas et al., 2005). 
Another mechanism affecting katanin activity is the presence of microtubule-
associated proteins (MAPs). Classical MAPs, such as MAP2 and Tau, bind to the 
surface of the microtubule and prompts to a large degree katanin activity. 
Microtubules in the axon are more resistant to severing by katanin than microtubules 
elsewhere in the neuron. When tau (but not MAP2 or MAP1b) is experimentally 
depleted from neurons, the microtubules in the axon lose their characteristic 
resistance to katanin (Qiang et al., 2006). Beside katanin neurons also express 
another microtubule severing protein known as spastin. However, these two proteins 
participate differently in axonal branch formation. P60-katanin is more highly 
expressed in the neuron, but spastin is more concentrated at sites of branch 
formation. During axonal branch formation, microtubule severing is based on local 
concentration of spastin at branch sites and on local detachment from microtubules 
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of molecules such as tau that regulate the severing properties of p60-katanin. It has 
been shown that tau protection from severing is greater in case of p60 katanin than 
spastin (Yu et al., 2008).  A recent study conducted on transgenic mice model of 
Alzheimer's disease revealed that katanin levels in the cortex and hippocampus of the 
transgenic mice was decreased compared to non-transgenic normal mice (Nichols et 
al., 2008). Microtubule based abnormalities in Alzheimer’s disease might consist of 
multiple phases. The first of which is an increase in the levels of tau, a microtubule 
associated protein, which blocks anterograde transport. The second phase represents 
an effort on the part of the neuron to combat the excess tau by hyperphosphorylating 
it leading to neurofibrillary tangles formation, which is one of the causes of the 
Alzheimer's disease, thus causing it to dissociate from the microtubules. It is known 
that hyper-phosphorylated tau cannot bind microtubules. Failure of tau binding to 
microtubules causes destabilization by increased de-polymerization leaving tau-
deprived microtubules more accessible to severing proteins. As a result, axonal 
degeneration occurs. Model for microtubule-based axonal degeneration in 
Alzheimer’s disease is illustrated in figure 1.9. This observation is completely new 
and might indicate targeting the microtubule severing protein as a possible 
therapeutic strategy for Alzheimer's disease (Baas and Qiang, 2005). 
 
Figure 1.9 : Model for microtubule-based axonal degeneration in Alzheimer’s                                      
disease (Baas and Qiang, 2005). 
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1.5 Transcriptional Machinery and Regulation in Eukaryotes 
Transcription of a eukaryotic protein-coding gene is preceded by multiple events; 
these include decondensation of the locus, nucleosome remodeling, histone 
modifications, binding of transcriptional activators and coactivators to enhancers, 
promoters, and recruitment of the basal transcription machinery to the core promoter 
(Smale and Kadonaga, 2003). The many thousands of genes coding for proteins in 
eukaryotes are transcribed by common multiprotein machinery. The control of this 
process is predominantly mediated by a network of thousands of sequence-specific 
DNA binding transcription factors that interpret the genetic regulatory information, 
such as in transcriptional enhancers and promoters, and transmit the appropriate 
response to the RNA polymerase II transcriptional machinery. 
Transcription is a complex process that relies on the collective action of the 
sequence-specific factors along with the core RNA polymerase II transcriptional 
machinery, an assortment of coregulators that bridge the DNA binding factors to the 
transcriptional machinery, a number of chromatin-remodeling factors that mobilize 
nucleosomes, and a variety of enzymes that catalyze the covalent modification of 
histones and other proteins (Kadonaga, 2004). Chromatin assembly is a fundamental 
biological process by which nuclear DNA is packaged into nucleosomes. The DNA 
of eukaryotes is ordinarily refractory to transcription because of its organization in 
nucleosomes (Fyodorov and Kadonaga, 2001). It is wrapped twice around an 
octamer of histone proteins, which interferes with many DNA transactions. 
Nucleosomes thus, serve as general gene repressors. They help assure the inactivity 
of all genes in eukaryotes except those whose transcription is brought about by 
specific positive regulatory mechanisms (Boeger et al., 2005). The packaging of 
DNA into chromatin provides the cell with the means to compact and to store its 
nuclear DNA, but it also creates an impediment to the function of DNA binding 
factors. To counterbalance the repressive nature of chromatin, a variety of chromatin 
remodeling factors use the energy of ATP hydrolysis to facilitate the interaction of 
proteins with nucleosomal DNA (Fyodorov and Kadonaga, 2001).  
  
17
 
Figure 1.10 : Overview of transcription control in multicellular eukaryotes (Lodish et al. 2004). 
A first indication of how repression by the nucleosome is relieved came from 
nuclease digestion of chromatin, showing an increase in accessibility of promoter 
DNA upon transcriptional activation (Boeger et al., 2005). Recently, it was found 
that active promoters are associated with histones modified in various                      
ways, including acetylation, deacetylation, phosphorylation, dephosphorylation, 
ubiquitylation, deubiquitylation, ADP-ribosylation, methylation and sumoylation. 
Some of these modifications are correlated with and apparently required for 
transcription (Wu and Grunstein, 2000, Shiio and Eisenman, 2003).  In eukaryotes, 
the core promoter serves as a platform for the assembly of transcription preinitiation 
complex (PIC) that includes  TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH 
(transcription factor IIA, IIB, IID, IIE, IIF, IIH respectivily) and RNA polymerase II 
(pol II), which function collectively to specify the transcription start site (Thomas 
and Chiang, 2006). The events leading to transcription of eukaryotic protein-coding 
genes culminate in the positioning of RNA polymerase II at the correct initiation site, 
the core promoter (Smale and Kadonaga, 2003). This transcription preinitiation 
complex could only support basal transcription and does not respond to the addition 
of gene-specific activator proteins. This observation led to the unexpected discovery 
and purification of ‘‘mediator’’, a multiprotein complex composed of ~20 different 
proteins. The role of mediator in all eukaryotes from yeast to humans is to transfer 
positive and negative signals from DNA-binding, gene-specific transcription factors 
to RNA polymerase II and the general transcription factors. With the isolation of 
mediator, the three essential components of gene regulation and transcription in 
eukaryotes had been established; namely the general transcription factors, mediator 
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and RNA polymerase II (Kornberg, 2005). A simple diagram of transcription 
initiation complex is given in figure 1.11. 
 
Figure 1.11: A cartoon of a eukaryotic transcription initiation complex  (Thelander, 2006). 
The TATA box (also named the Goldberg-Hogness box after its discoverers) was the 
first core promoter element identified in eukaryotic protein-coding genes with 
TATAAA consensus sequence found 25 to 30 bp upstream of the transcription start 
site. Following the early studies, it was speculated that the TATA box might be 
strictly conserved and essential for transcription initiation from all protein-coding 
genes from yeast to man. However, as the promoters for more and more genes were 
sequenced and characterized, the prevalence of the TATA box diminished. A 
database analysis of human genes revealed that TATA boxes were present in 32% of 
1031 potential core promoters (Smale and Kadonaga, 2003). Core promoters can be 
classified into those that contain a functional TATA-box, TATA-box paired with an 
initiator (Inr), Inr element with downstream promoter elements (DPM), and CpG 
island-rich promoters which lack all three core elements (Smale, 2001). Figure 1.12 
shows some of the sequence elements that can contribute to basal transcription from 
a core promoter (Smale and Kadonaga, 2003). 
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Figure 1.12 : Core promoter motifs (Smale and Kadonaga, 2003). 
Numerous housekeeping genes lack both TATAAA and CAAT sequence motifs but 
contains multiple GC boxes, determining the functional role of multiple GC boxes in 
the absence of TATAA and CCAAT motifs is crucial to the understanding of 
transcriptional regulation of these promoters. Transcriptional initiation is controlled 
by upstream GC-box interactions in a TATA-less promoter (Blake et al., 1990). The 
CpG dinucleotide, a DNA methyltransferase substrate, is underrepresented in the 
genomes of many vertebrates because 5-methylcytosine can undergo deamination to 
form thymine, which is poorly repaired by DNA repair enzymes. However, 0,5–2 
kbp stretches of DNA exist that possess a relatively high density of CpG 
dinucleotides. The human genome contains ~29,000 of these CpG islands. Most 
importantly, it has been estimated that, in mammals, CpG islands are associated with 
approximately half of the promoters for protein coding genes. During early 
mammalian development, DNA methylation decreases substantially throughout the 
genome, followed by de novo methylation to normal levels prior to implantation. 
CpG islands are largely excluded from this phase of de novo methylation, and most 
remain unmethylated in all tissues and at all stages of development. Despite the 
prevalence of promoters associated with CpG islands, the elements that are 
responsible for their core promoter function remain poorly defined. In general, it has 
been difficult to identify core promoter elements within CpG islands that are 
essential for promoter function. One common feature of CpG islands is the presence 
of multiple binding sites for transcription factor Sp1. Transcription start sites are 
often located 40–80 bp downstream of the Sp1 sites, this suggests that Sp1 may 
direct the basal machinery to form a preinitiation complex within a loosely defined 
window (Smale and Kadonaga,  2003). The dinucleotide CG is underrepresented in 
vertebrate DNAs, and the presence of a CG-rich region, or CpG island, just upstream 
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of the start site is a distinctly nonrandom distribution. For this reason, the presence of 
a CpG island in genomic DNA suggests that it may contain a transcription-initiation 
region (Lodish et al., 2004). 
1.6 Cis-acting regulatory elements 
Cis-acting regulatory elements are control regions that regulate transcription of 
genes. Cis-acting regulatory elements that activate transcription of genes include 
proximal promoter, core promoters and enhancers and boundary elements. 
Core promoters comprise DNA sequence motifs within 240 to 140 nucleotides 
relative to the RNA start site (such as the TATA box, TFIIB recognition element 
(BRE), initiator (Inr), and the downstream promoter element (DPE)) that, in the 
appropriate combinations, are sufficient to direct transcription initiation by the basal 
RNA polymerase II transcriptional machinery (Blackwood and Kadonaga, 1998). 
Most core promoter elements appear to interact directly with components of the basal 
transcription machinery (Smale and Kadonaga, 2003). 
Immediately upstream of the core promoter (from about 250 to 2200 bp relative to 
the RNA start site), there are typically multiple recognition sites for a subgroup of 
sequence specific DNA-binding transcription factors, which include Sp1, CTF 
(CCAAT-binding transcription factor; also called nuclear factor ±I, or NF-I), and 
CBF (CCAAT-box± binding factor; also called nuclear factor±Y, or NF-Y) named 
proximal promoter (Blackwood and Kadonaga, 1998). 
One of the characteristic features of eukaryotic gene expression is the existence of 
sequence elements located at great distances from the start site of transcription which 
can influence the level of gene expression. These elements can be located upstream, 
downstream or within a transcription unit and function in either orientation relative 
to the start site of transcription. They act by increasing the activity of a promoter, 
although they lack promoter activity themselves and are hence referred to as 
enhancers (Latchman, 2004). Transcriptional control regions often contain multiple, 
autonomous enhancer modules that vary from about 50 bp to 1.5 kbp in size. Each of 
these modules appears to be designed to perform a specific function, such as the 
activation of its cognate gene in a specific cell type or at a particular stage in 
development (Blackwood and Kadonaga, 1998). 
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Boundary elements are DNA segments (from about 0.5 to 3 kbp) that are thought to 
function as transcriptionally neutral DNA elements that block, or insulate, the 
spreading of the influence of either positive DNA elements (such as enhancers) or 
negative DNA elements (such as silencers, or heterochromatin-like repressive 
effects) (Blackwood and Kadonaga, 1998). 
1.7 Trans-acting Regulatory Elements 
Transcription factors are trans-acting regulatory elements that must be stably 
expressed, translocate to the nucleus, bind DNA or other proteins in order to localize 
to the target gene, and interact with other factors including the RNA polymerase 
basal machinery, co-activators or co-repressors, and chromatin-remodeling 
complexes to regulate transcription (Gill, 2005). 
The control of DNA binding by eukatyotic transcription factors represents an 
important regulatory mechanism. The DNA control elements that bind transcription 
factors often are located much further from the promoter they regulate. In some 
cases, transcription factors that regulate expression of protein-coding genes in higher 
eukaryotes bind at regulatory sites tens of thousands of base pair either upstream or 
downstream from the promoter. As a result of this arrangement transcription of a 
single promoter may be regulated by binding of multiple transcription factors to 
alternative control elements, permitting complex control of gene expression (Lodish 
et al., 2004). 
Although the majority of transcription factors that have so far been described act in a 
positive manner, a number of cases have now been reported in which a transcription 
factor exerts an inhibitory effect on transcription initiation. This effect can occur by 
indirect repression, in which the repressor interferes with the action of an activating 
factor so preventing it stimulating transcription. Alternatively, it can occur via direct 
repression in which the factor reduces the activity of the basal transcriptional 
complex (Latchman, 2003). 
Post-translational modification of many transcription factors by SUMO, small 
ubiquitin-like modifier that is covalently linked to lysine residues, has been 
correlated with different effects on their activity but mostly inhibition of transcription 
by modulating their ability to interact with their partners and controlling their 
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stability (Verger et al., 2003, Hay, 2005). Recent studies suggest that SUMO-
dependent interactions with transcriptional co-repressors such as histone deacetylases 
(HDACs) might be one mechanism that contributes to regulation of transcription by 
SUMO, suggesting that complex interplay between acetylation and SUMOylation 
might be important for the regulated expression of many genes (Gill, 2005). 
The control elements required for the transcription of a gene can be identified via 
some experimental approaches. DNA fragments with varying extents of sequence 
upstream of a start site are cloned in front of a reporter gene. By constructing and 
analyzing a 5’-deletion series, effects of promoter parts on expression can be 
examined. In this way, identification of key nucleotide sequences in the promoter 
which are important in gene expression can be revealed (Lodish et al., 2004). The 
experimental approach is illustrated in figure 1.13. 
 
Figure 1.13 : Experimental procedure to identify control elements (Lodish et al., 2004).  
1.7 .1 ETS domain transcription factor 
Members of this family were originally identified on the basis of a region of primary 
sequence homology with the protein product of the v-ets oncogene encoded by the 
E26 avian erythroblastosis virus (Leprince et al., 1983). It was named after the 
retrovirus E26 (E twenty six-specific) (Dittmer and Nordheim, 1998). After 
comparing the sequence the sequence-specific DNA binding properties of the 
proteins encoded by the murine homolog of the ets-1 proto-oncogene and two ets-
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related genes, murine PU.1 and Drosophila E74 it has been found that the protein 
products of these genes share sequence similarity within a region of 85 amino acids. 
This amino acid sequence similarity, combined with the observation that these 
proteins bind similar DNA sequences, provided the basis for the ETS-domain a new 
family of eukaryotic DNA-binding proteins (Karim et.al, 1990). 
So far, approximately 30 members of the family have been identified in mammals, 
which are shown to encode nuclear transcription factors to regulate gene expression. 
A characteristic feature of this family is that they shear an evolutionarily-conserved 
Ets domain of about 85 amino acid residues that mediate binding to purine-rich DNA 
sequences with a central GGAA/T core consensus and additional flanking 
nucleotides (Oikawa and Yamada, 2003).  
ETS domain proteins can be subclassified philogenetically according to the sequence 
of ETS-domains primarily, the position of this domain in the protein and the 
presence of other specific conserved domains and motifs. The 13 subfamilies 
identified are: ETS, TEL, YAN, SPI, ERG, PEA3, ELF, DETS4, ELK, GABP, 
ER71, ERF, and ESE (Laudet et al., 1999). Some of the members structures  are 
shown in figure 1.14.  
 
Figure 1.14: ETS-domain transcription factor subfamilies and their structures                          
(Oikawa and Yamada, 2003). 
ETS domain proteins can function as either transcriptional activators or repressors 
and in most cases, their activities are regulated by signal transduction pathways 
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(Sharrocks et.al., 1997). In addition, it was shown that some family members have 
both repressive and activating abilities, making the strict distinction impossible 
(Sharrocks, 2001). These signaling pathways include MAP kinases, Erk1 and 2, p38 
and JNK, the PI3 kinases and Ca2+-specific signals activated by growth factors or 
cellular stresses (Yordy and Helmericks, 2000). 
Biologically, ETS-domain transcriptional factors appear to have distinct roles in 
regulating cellular proliferation and differentiation during both embryonic 
development and in the adult (Sharrocks et.al., 1997). 
Some ETS family proteins are expressed ubiquitously, some in a tissue-specific 
manner (Oikawa and Yamada, 2003). Expression patterns of representative Ets 
family proteins are shown in figure 1.15. 
 
Figure 1.15: Tissue distribution of major ETS family proteins (Oikawa and Yamada, 2003). 
All known ETS-domain transcription factors bind to sites containing a central 
“GGA” trinucleotide motif. The residues flanking this motif decide whether a 
particular ETS-domain will bind the site. The ETS DNA-binding domain is 
characterized by the presence of three conserved tryptophans separated by 17-21 
amino acids (Karim et al., 1990). Owing to its lack of sequence similarity to other 
known DNA-binding domains, the ETS-domain was initially thought to represent a 
novel structural DNA binding motif. However, after revealing of three-dimensional 
structure of three members of the family; Fli-1, Ets-1 and PU.l/Spi-1 the ETS-
domain was placed in the winged helix-turn-helix superfamily of DNA-binding 
proteins. Due to high amino acid conservation amongst the ETS-domain of 
individual family members, this structural motif and mode of DNA binding are likely 
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to be conserved in all ETS domain proteins (Sharrocks et.al., 1997). DNA-binding 
sites of different ETS-domain transcription factors are shown in figure 1.16. 
 
Figure 1.16: DNA-binding sites of different ETS-domain transcription factors        
(Sharrocks et.al., 1997). 
Due to high sequence conservation within these DNA-binding domains, members of 
particular families bind to similar DNA sequences. Thus, mechanisms must be in 
place to prevent promiscuous binding to inappropriate sites and provide specificity to 
ensure binding to the correct sites. One such mechanism is autoinhibition, whereby 
proteins block their own DNA binding by employing cis-acting inhibitory modules. 
These modules also often act to block other activities of transcription factors such as 
transcriptional activation or nuclear localization. Many transcription factors are 
controlled by cis-acting autoinhibitory modules that are thought to act by blocking 
random DNA binding in the absence of appropriate regulatory clues (Greenall et al., 
2001). 
1.7.1.1 PEA3 Family 
The PEA3 (Polyomavirus Enhancer Activator 3) family of ETS-domain transcription 
factors contains three different proteins, PEA3 (also called E1AF or ETV4), ERM 
(also called ETV5), and ER81 (also called ETV1) which are 95% identical within the 
DNA binding (ETS) domain, more than 85% identical in the 32-residue acidic 
domain (AD) located in the amino-terminal part of the proteins, and almost 50% 
identical in the final 61 residues corresponding to the carboxy-terminal tail (Ct) 
(Launoit et al., 1997). The conserved domains of PEA3 family of ETS-domain 
transcription factors can be seen in figure 1.17. 
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Figure 1.17 : Sequence alignment of human PEA3 group proteins (Launoit et al., 1997). 
Members of this group of proteins are conserved at both the sequence and functional 
levels in vertebrates as diverse as humans and zebrafish. Biological roles for PEA3 
family members include promoting muscle cell differentiation and the definition of 
connecting muscle motor and sensory neurons. Embryonic expression patterns and 
aberrant expression in metastatic tumors, suggest a role for PEA3 proteins in 
regulating cell motility during organogenesis/development and during tumor 
progression (Greenall et al., 2001). 
In 1998, zebrafish PEA3 was characterized and a high degree of sequence 
conservation is observed in the ETS DNA binding domain and acidic transcriptional 
activation domain. Moreover zebrafish PEA3 also exhibits a virtually 
indistinguishable DNA binding specificity to mammalian subfamily members and is 
autoregulated by cisacting inhibitory domains. The developmental pattern of PEA3 
expression suggests that it may play a role in the development of the somites and in 
regionalisation of the nervous system (Brown et al., 1998).  
Other roles of PEA3 group transcription factors are shown recently, they are found to 
be expressed in tissues undergoing branching morphogenesis and promote formation 
of duct-like structures by mammary epithelial cells in vitro (Chotteau-Lelièvre et al., 
2003) and also they are thought to play a role in epithelial–mesenchymal interactions 
during lung organogenesis (Lui et al., 2003).  
Recently it was shown that PEA3 group transcription factors have a role in metastatic 
process, playing a role in many human cancer including oral tract, lung, stomach, 
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liver, colon, ovary, breast and endometrium. In particular, they regulate the 
expression of target genes involved in metastasis. Those genes are several matrix 
metalloproteases, which are enzymes degrading the extracellular matrix during 
normal remodelling events and cancer metastasis (Davidson et al., 2003, Bieche et 
al., 2004, Launoit et al., 2006). 
The pea3 ETS transcription factor is overexpressed in the vast majority of human 
breast tumors, in the epithelial cells of the mammary gland and is found to be 
required for HER2/Neu-mediated mammary oncogenesis (Sheperd et al., 2001). 
The pea3 subfamily transcription factors also play a key regulatory role in mammary 
gland development,  they are found to be normally expressed in the primitive 
epithelium of mouse mammary buds during embryogenesis, and these three genes 
are expressed in epithelial progenitor cells during postnatal mammary gland 
development (Kurpios et al., 2003). 
It has been shown by means of in situ hybridization experiments that all three genes 
are expressed in numerous developing murine organs including brain, kidney, lung, 
and heart (Chotteau-Lelièvre et al., 1997). At the mRNA level, ERM has been 
classified in adult humans and mice as a ubiquitously expressed gene with its highest 
expression in the brain and in the placenta. ER81 displays an expression pattern with 
high expression levels in human and murine lung, heart, and brain. Interestingly, 
PEA3, whose expression is very weak in normal human tissues, is expressed in an 
extensive series of nonhematopoeitic cell lines (Launoit et al., 1997). 
The human and mouse ER81, ERM, and PEA3 genes are structured in 13–14 exons 
distributed over more than 15 kbp of genomic DNA. In the human genome, ERM is 
located on chromosome 3 at position 3q27–29, PEA3 on chromosome 17 at position 
17q21, and ER81 on chromosome 7 at position 7q21 (Launoit et al., 2006). 
Like many transcription factors, the PEA3 group members also undergo post-
translational modification that regulates their transactivation capacity. The most 
common modification found in the PEA3 group proteins is phosphorylation, as they 
are targets of the MAPK pathway including Ras, Raf-1, MEK, ERK-1, and ERK-2. 
Phosphorylation of specific serine and threonine residues generally increases the 
transactivation capacity of the PEA3 group member. Post-translational modifications 
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at lysines also play crucial roles in the regulation of transcription, generally on 
histone proteins but also on transcription factors (Launoit et al., 2006).  
1.7 .1.2 TCF Family 
Ternary Complex Factor (TCF) family is the most studied subfamily of ETS factors. 
The first TCF transcription factor was identified in the nuclear extract of HeLa cells 
which formed a ternary complex with Serum Response Factor (SRF) on the c-fos 
promoter. This novel protein was called p62 due to its 62000 Da molecular weight. 
Then, it was shown to be homologous to Elk-1 (Ets-like 1) protein, which had been 
cloned previously by Hipskind et al. in 1991. Later, two homologous proteins of  
Elk-1, Sap1 and Net/Sap2 have been identified (Sharrocks, 2002). 
Beside the three TCFs Elk-1, Sap-1a and Net identified, there are also their isoforms 
sElk-1, ∆Elk-1, Sap-1b, Net b and Net c. 
TCFs share 4 similar regions, known as A, B, C and D domains, which were 
identified by sequence comparison between Elk-1 and Sap-1. The N-terminal A 
domain corresponds to the ETS DNA binding domain. It has also been demonstrated 
to act as a transcriptional inhibitor in Elk-1 by recruiting corepressors and DNA 
binding inhibitors, and to contain a nuclear export signal in Net. The B domain 
interacts with the MADS box transcription factor family member SRF and allows 
ternary complex formation. The C-terminal C domain is an activation domain that is 
activated by phosphorylation by Mitogen-Activated Protein Kinases (MAPK) 
containing multiple S/T-P MAP kinase phosphorylation sites. The D domain is a 
docking site for MAP kinases as well as a nuclear localization signal in Net 
(Buchwalter et al,, 2004). Elk-1 is shown to contain a novel class of repression 
domain (R motif) in its C-terminal region, which reduce its basal transcriptional 
activity and dampen its response to mitogenic signals (Yang et al., 2002). Structure 
of TCF subfamily members is shown in figure 1.18. 
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Figure 1.18 : Structure of TCF subfamily members (Buchwalter et al,, 2004). 
Elk-1 is the best studied of the TCFs, a role for Elk-1 in neuronal function has been 
proposed based on its expression pattern. Elk-1 mRNA is located in various adult rat 
brain structures, including the soma, dendrites and axon terminals of neurons 
(Sgambato et al., 1998). In addition, sElk-1, the shorter isoform, has been shown to 
play an opposite role to Elk-1 in an in vitro model of neuronal cell differentiation. By 
inhibiting Elk-1 transactivating properties, sElk-1 could promote differentiation, 
whereas Elk-1 alone drives cell cycle progression through activation of c-fos 
(Sharrocks, 2002).  
Elk-1 is a direct target of the MAP kinase pathways, when phosphorylated by MAP 
kinases at Serine 383, its activation is triggered via the recruitment of the mediator 
complex through Sur2 but its R domain causes suppressing of its activity. It has been 
shown that SUMO modification of the R motif is the cause of this repression. There 
is a dynamic interplay between the activating MAPK pathway and SUMO pathway. 
When the MAPK pathway is activated, it stimulates the loss of SUMO conjugation 
and hence the repressive activity of the R motif is lost (Yang et al., 2003). The 
dynamic interplay is illustrated in figure 1.19. 
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Figure 1.19: Dynamic interplay of  SUMO and ERK pathways to regulate                                         
the transcriptional activity of Elk-1 (Yang et al., 2003). 
The mechanism of SUMO modification leading to Elk-1 repression model is 
revealed in 2004. It has been shown that histone deacetylase 2 (HDAC2) interacts 
preferentially with SUMO-modified Elk-1. Inhibition of HDAC2 with chemical 
inhibitors or by RNAi de-repressed activity of SUMOylated Elk-1, and chromatin 
immunoprecipitation analysis revealed that increased HDAC2 leads to decreased 
histone acetylation and hence transcriptional repression at Elk-1 target genes. These 
studies provided evidence that histone deacetylase HDACs contribute to 
transcriptional inhibition by SUMO (Yang et al., 2004). 
Recently it has been shown that egr-1 gene is repressed by Elk-1 in normally cycling 
SH-SY5Y neuroblastoma cell line in a SUMO-dependent manner. Constitutively 
active Elk-1 construct, Elk-VP16, is found to be capable of activating the egr-1 gene 
expression but a SUMOylation mutant of Elk-1, namely ElkK2R, was found to be 
involved in repression of the egr-1 promoter. Those findings suggest that 
neuroblastoma cells regulate the levels of egr-1 protein through HDAC recruitment 
to the egr-1 promoter via Elk-1 and resulting repression of the promoter, thereby 
escaping apoptosis and surviving (Demir and Aksan-Kurnaz, 2008). This model of 
action is illustrated in figure 1.20. 
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Figure 1.20: This model of action of repression-activation of Elk-1 on egr-1 promoter                            
(Demir and Aksan Kurnaz, 2008). 
The SUMOylation sites for Elk-1 are also identified, SUMO is conjugated on either 
lysines 230, 249, or 254. Mutation of all three sites is found to be necessary to fully 
block SUMOylation in vitro and in vivo. The mutant form Elk-1 (3R) is found to 
shuttle more rapidly to nuclei of Balb/C cells fused to transfected HeLa cells. When 
SUMO-1 or -2 are coexpressed, it is shown to strongly reduce shuttling by Elk-1 
without affecting that of Elk-1(3R), indicating that SUMOylation regulates nucleo-
cytoplasmic shuttling of Elk-1 (Salinas et al., 2004). 
In a recent study, it has been shown  that Elk-1 colocalized with microtubules in 
hippocampal neuron cultures and SH-SY5Y neuroblastoma cell lines, and that Elk-1 
protein biochemically interacted with microtubules in vitro. It was further 
demonstrated that upon serum induction, most of the phospho-Elk-1 translocates to 
the nucleus, which is independent of translation. This leads to the idea that Elk-1 is 
anchored to neuronal microtubules in resting or unstimulated cells. Upon stimulation, 
its phosphorylated form, phospho-Elk-1, relocalizes to the nucleus in neurons where 
it is proposed to regulate neuronal target genes (Demir et al., 2008). 
1.7.2 Sp Family Transcription Factors 
The Sp family is a family of transcription factors that bind to cis-elements in the 
promoter regions of various genes. Regulation of transcription by Sp proteins is 
based on interactions between a GC-rich binding site (GGGCGG) in DNA and C-
terminal zinc finger motifs in the proteins (Kishikawa et al., 2002). The human 
transcription factor Spl (Specificity protein 1) is one of the very first cellular 
transcription factors to be identified in the early 1980s as a factor able to bind and 
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activate the SV40 early promoter (Briggs et al.,1986). Spl protein binds to              
the G-rich sequences present in a variety of cellular and viral promoters and 
stimulates their transcriptional activity. Sp1 consists of three contiguous        
Cys2His2 zinc-finger domains that bind to the decanucleotide consensus sequence                  
5’GGGGCGGGGC 3’ and similar sequences that are referred to as GC boxes (Park 
et al., 1998). For some time it has been known that the general transcription factor 
Sp1 can bind to and act through the GC-boxes and it was generally accepted that this 
protein is an extremely versatile protein involved in the expression of many different 
genes. However, it became clear that Sp1 is not the only protein acting through ‘Sp1-
binding sites’ but simply represents the first identified and cloned protein of a small 
protein family (Suske, 1999). A number of other GC and/or GT box-binding factors 
homologous to Spl have been isolated, namely Sp2, Sp3 and Sp4, and the two more 
distantly related factors, BTEB1, BTEB2 (basic transcription element binding 
protein1 and 2) (Lania et al., 1997), and also TIEG1, TIEB2 (TGF-β inducible early 
protein genes 1 and 2) (Suske,1999). In addition, another subgroup of zinc finger, 
Sp-1 like proteins the so called Krüppel-like factors (KLF) were also identified 
(Lomberk and Urrutia, 2005). Sp1-like/KLF transcription regulators may take part in 
virtually all facets of cellular function, including cell proliferation, apoptosis, 
differentiation, and neoplastic transformation. Individual members of the Sp1-
like/KLF family can function as activators or repressors depending on which 
promoter they bind and the coregulators with which they interact (Kaczynski et al., 
2003).  
All four human Sp-family members have similar domain structures. They contain 
three zinc fingers close to the C-terminus and a glutamine-rich domain adjacent to 
serine/threonine stretches in their N-terminal region. Structural features of Sp-
proteins are illustrated in figure 1.21. Colored boxes indicate regions of the proteins 
that are rich in glutamine (red) and serine/threonine (yellow) residues. The region 
preceding the first zinc finger (+/−) is rich in charged amino acids. The black boxes 
represent the zinc fingers, known activation (AD) and inhibitory domains (ID) are 
also indicated (Suske, 1999). 
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Figure 1.21: Structural features of  Sp-proteins (Suske, 1999). 
Sp1, Sp3 and Sp4 recognize the classical Sp-1 binding site with identical affinity. 
Futhermore, Sp1 and Sp3 are structurally and functionally highly related, whereas 
Sp2 appears to have distinct DNA binding specificity, shown to bind GT-rich 
elements, and its functional roles are not clearly defined. Sp1 is known to be 
phosphorylated and glycosylated, and it is capable of forming homotypic interactions 
leading to multimeric complexes. (Suske, 1999). In contrast to Sp1 and Sp3, which 
are ubiquitous transcription factors, Sp4 expression is restricted to a few tissues; 
predominantly in the neuronal tissues and in certain epithelia. Functional analyses 
have shown that Sp4, like Sp1, is a transcriptional activator, whereas Sp3 has been 
shown to both repress and activate transcription (Park et. al., 1998). The 
experimental conditions which are needed for Sp3 to act as a strong activator or a 
transcriptional inactive molecule, which represses Sp1-mediated activation, are not 
completely understood. The structure and the arrangement of the recognition sites 
appear to determine whether Sp3 is transcriptionally inactive and can repress Sp1-
mediated activation or whether it acts as a strong activator (Suske, 1999). A study 
conducted on human dopamine transporter gene promoter demonstrated that both 
Sp3 and Sp1 serve as strong trans-activators of the promoter, albeit with different 
efficacy and via different Sp-binding sites (Wang and Bannon, 2005). Sp1 and Sp3 
were found to be bound to the same cis-element in DNA methyltransferase gene 1 
promoter and in human secretin receptor gene promoter, and the relative ratio of Sp1 
to Sp3 is one of the critical factors controlling the tissue-specific and stage-specific 
expressions of those genes (Kishikawa et al., 2002, Pang et al., 2004). 
1.8 Genetic reporter System 
Reporter genes or markers provide convenient means to identify and analyze the 
regulatory elements of genes. Certain genes are chosen as reporters because the 
characteristics they confer on organisms expressing them are easily identified and 
measured, or because they are selectable markers. Commonly used reporter genes are 
chloramphenicol acetyltransferase, β-galactosidase, β-glucuronidase, lusiferase, 
  
34
alkaline phosphatese and green fluorescent protein (Sambrook and  Russell, 2001). 
The purpose of the reporter assay is to measure the regulatory potential of an 
unknown DNA-sequence. Reporter genes can be used to assay for the activity of a 
particular promoter in a cell or organism. This can be done by linking a promoter 
sequence to an easily detectable reporter gene and the reporter gene product's activity 
is quantitatively measured. The results are normally reported relative to the activity 
under a consensus promoter known to induce strong gene expression. Standard 
recombinant methods are used to join the regulatory sequence of interest to a reporter 
gene in an expression vector. The resulting recombinant is then introduced into an 
appropriate cell line, where its expression is detected by measurement of the reporter 
mRNA or the reporter protein, or, in the case of enzyme reporter, by assaying for the 
relevant cataytic activity. Most of the detection methods are sensitive, specific, 
quantitative, reproducible, and rapid to perform. Reporter systems are used to 
measure transcriptional activity in particular to study promoters and enhancers and 
their interactions with cis-acting elements and trans-acting proteins (Sambrook and  
Russell, 2001). 
1.8 .1 Dual-Luciferase Reporter Assay System 
Dual reporters are commonly used to improve experimental accuracy. The term dual 
reporter refers to the simultaneous expression and measurement of two individual 
reporter enzymes within a single system. Typically, the experimental reporter is 
correlated with the effect of specific experimental conditions, while the activity of 
the co-transfected control reporter provides an internal control that serves as the 
baseline response. Normalizing the activity of the experimental reporter to the 
activity of the internal control minimizes experimental variability caused by 
differences in cell viability or transfection efficiency. Other sources of variability, 
such as differences in pipetting volumes, cell lysis efficiency and assay efficiency, 
can be effectively eliminated.  
In the Dual-Luciferase Reporter (DLR) Assay System, the activities of firefly 
(Photinus pyralis) and Renilla (Renilla reniformis) luciferases are measured 
sequentially from a single sample. The firefly luciferase reporter is measured first 
and after quenching the reaction, the Renilla luciferase reporter is simultaneously 
measured. Firefly and Renilla luciferases, because of their distinct evolutionary 
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origins, have dissimilar enzyme structures and substrate requirements. These 
differences make it possible to selectively discriminate between their respective 
bioluminescent reactions.  
Firefly luciferase, which is a 61 kDa monomeric protein that does not require 
posttranslational processing for enzymatic activity functions as a genetic reporter 
immediately upon translation. Photon emission is achieved through oxidation of 
beetle luciferin in a reaction that requires ATP, Mg2+ and O2 shown in figure 1.18. 
Under conventional reaction conditions, the oxidation occurs through a luciferyl-
AMP intermediate that turns over very slowly. As a result, this assay chemistry 
generates a flash of light that rapidly decays after the substrate and enzyme are 
mixed. The reaction equation is given in figure 1.22 (Promega Technical Manual 
E1910, 2006). 
 
Figure 1.22: Bioluminescent reaction catalyzed by firefly luciferase                                                 
    (Promega Technical Manual E1910, 2006). 
Renilla luciferase, a 36 kDa monomeric protein, like firefly luciferase, that does not 
require post-translational modification may function as a genetic reporter 
immediately following translation. The luminescent reaction catalyzed by Renilla 
luciferase utilizes O2 and coelenterate-luciferin shown in figure 1.23. 
 
Figure 1.23 : Bioluminescent reaction catalyzed by renilla luciferase                                           
   (Promega Technical Manual E1910, 2006). 
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1.9. Aim of the Study 
Katanin is a heterodimeric protein that severes microtubules by hydrolyzing ATP. 
Katanin consists of 60 kDa and 80 kDa polypeptides. 60 kDa subunit (p60) has the 
enzymatic activity to break microtubules, whereas 80 kDa subunit (p80) has a role in 
localization of the protein complex in the cell. Katanin has been shown to have roles 
for microtubule severing in mitotic cells including release of microtubules from 
centrosome, depolymerization of microtubule minus ends in the mitotic spindle. 
Despite the importance of this protein, its transcriptional regulation has not been 
studied, and the promoter has not yet been characterized.  
The promoter site of human KATNB1 gene coding for p80, is high in CG 
dinucleotides. It is known that the cytosine and guanine rich sequences in the 
promoter regions of genes are the candidate regions for transcription factors binding. 
In this study, in order to understand the transcriptional regulation of human 
KATNB1, putative promoter region in the upstream of KATNB1 gene will be 
characterized and its potential effect on katanin expression regulation will be 
revealed. Identification of transcription factor binding sites in the promoter of the 
KATNB1 gene is in a great importance to understand temporal gene expression 
pattern of katanin, which slightly differs between different stages of development. 
Identification of this gene regulation pattern will be a pioneer study for 
understanding the gene expression regulation of KATNB1 gene. 
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2. MATERIALS AND METHODS 
2.1. Materials  
2.1.1. Cell lines 
SH-SY5Y Human metastatic neuroblastoma cell line was a gift of Assoc. Prof. Dr. 
Işıl Aksan Kurnaz. Those cells are clonal subline of the neuroepithelioma cell line 
SK-N-SH that had been established in 1970 from the bone marrow biopsy of a 4-
year-old girl with metastatic neuroblastoma. 
2.1.2. Bacterial Strains 
 
▪ Escherichia coli DH5α strain [F-, φ80dlacZ∆M15, ∆(lacZYA-argF)U169, deoR, 
recA1, endA1, hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1] 
▪ Escherichia coli dam- dcm- GM2163 strain [F-, dam-13::Tn 9 dcm-6 hsdR2 leuB6 
his-4 thi-1 ara-14 lacY1 galK2 galT22 xyl-5 mtl-1 rpsL136 tonA31 tsx-78 supE44 
McrA- McrB-] (Fermantas, M009). 
2.1.3. Molecular Cloning Assays 
 
▪ 25mM MgCl2 (Fermentas) 
▪ 2mM dNTP Mix (Fermentas) 
▪ MassRuler™ DNA Ladder Mix (Fermentas) 
▪ 6x DNA Loading Dye (Fermentas) 
▪ Agarose Low EEO (Applichem) 
▪ Taq polymerase 5u/µl (Fermentas) 
▪10X Taq Buffer with KCl (Fermentas) 
▪ FastDigest® HindIII Enzyme (Fermentas) 
▪ FastDigest® KpnI  Enzyme (Fermentas) 
▪ 10X FastDigest® Buffer (Fermentas) 
▪ T4 Ligase (Roche) 
▪ 10X Ligation Buffer (Roche) 
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▪ EtBr (Merck) 
▪ Tris Base (BDH Laboratory) 
▪ Glacial Acetic Acid (Fluka) 
▪ EDTA (Merck) 
▪ Hi-Di Formamide (Applied Biosystems) 
▪ Isopropanol (Fluka) 
▪ Molecular Biology grade Ethyl Alcohol (Fiedel-de Haën) 
▪ Primers (Alpha DNA) 
2.1.4. Bacterial Assays 
 
▪ Ampicillin (Sigma-Aldrich) 
▪ CaCl2.2H20 (Merck) 
▪ PIPES (BDH Laboratory) 
▪ Glycerol (Fluka) 
▪ Yeast Extract (Merck) 
▪ Agar (Merck) 
▪ Tryptone (BDH Laboratory) 
▪ NaCl (Fluka) 
▪ MgCl2 (Merck) 
▪ MgSO4(Fluka) 
▪ KCl (Fluka) 
▪ Glucose (Merck) 
2.1.5. Cell culture Assays 
▪ Dulbecco’s Modified Eagle Medium (DMEM)1X  (Gibco) 
▪ L-Glutamine solution, 200mM (Biochrom) 
▪ Fetal Bovine Serum (Gibco) 
▪ Penicilin/Streptomycin solution (100X) (Biochrom) 
▪ Trypsin/EDTA 0,25/0,02 solution (Biochrom) 
▪  Phosphate Buffered Saline (PBS) 10X pH=7,2  (Gibco) 
▪ DMSO (Fiedel-de Haën) 
▪ Transfast Transfection Reagent (Promega) 
▪ 25cm2, 75cm2 Tissue Culture Flasks (TPP) 
▪ 24-well culture plate (TPP) 
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▪ 30cm Cell Scraper (TPP) 
▪ 5ml, 10ml, 25ml Serological pipettes (TPP) 
▪ 150ml Vacuum filtration system (TPP)  
▪ 50ml, 20ml, 10ml Syringes (Set Inject) 
▪ 0.22µm, 0.4µm syringe filters (TPP) 
2.1.6. Buffers and Solutions 
2.1.6.1. 50X TAE Buffer 
50X TAE Buffer used in 1X dilution was used in DNA gel electrophoresis to prepare 
the gel that DNA is loaded on and also as the tank buffer. The buffer contains 40 mM 
Tris Base, 20mM Glacial acetic acid and 1 mM EDTA (pH=8) in double distilled 
water (ddH20). 
2.1.6.2 CaCl2 Solution 
CaCl2 solution was used to prepare chemicaly competent E.coli cells to use in 
transformation. The solution contains 60mM CaCl2, 10mM PIPES and 15% glycerol 
in ddH2O. pH was adjusted to 6,4 to dissolve PIPES and then was filter sterilized 
with 0,4µm filter. 
2.1.6.3. LB Medium 
Luria Bertani (LB) Medium was prepared by dissolving 10 gram (g) tryptone, 5 g 
yeast extract, and 10 g NaCl in 1L dH20. The media was sterilized by autoclaving for 
15 minutes at 121°C. In order to make selection, ampicillin was added after the 
media was cooled down approximately to 55 °C.  
2.1.6.4. LB Agar Medium 
Luria Bertani (LB) Agar Medium was prepared by dissolving 10 gram (g) tryptone, 5 
g yeast extract, 10 g NaCl and 20 g Agar in 1L dH20. The media was sterilized by 
autoclaving for 15 minutes at 121°C. In order to make selection, ampicillin was 
added after the media was cooled down approximately to 55°C. After mixing the 
medium, the content was poured into 10mm Petri plates, approximatly 20ml per 
plate.  
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2.1.6.5. SOC Medium 
SOC medium was used to cultivate E. coli cells after heat shock transformation. 2 g 
tryptone, 5 g yeast extract, 0,058 g NaCl, 0.0186 g KCl, 0,095 g MgCl2, 0,23 g 
MgSO4 and 0,36 g glucose was dissolved in 100 ml in dH20 and sterilized at 121°C 
by autoclaving for 15 minutes. 
2.1.6.6. SH-SY5Y Culture Medium 
To prepare SH-SY5Y culture medium, DMEM containing 1 g/L glucose was 
supplemented with 10% FBS, 2 mM L-Glutamine and 1X Penicilin/Streptomycin 
and then filter sterilized with 0,2 µm filter. 
2.1.6.7. SH-SY5Y Freezing Medium 
To prepare SH-SY5Y freezing medium, DMEM containing 1g/L glucose was 
supplemented with 10% FBS, 2 mM L-Glutamine and 5% DMSO and then filter 
sterilized with 0,2 µm filter according to manufacturer instructions. 
2.1.7. Vectors 
2.1.7.1. pGL3-Basic 
The pGL3-Basic luciferase reporter vector (Promega, E1751) provides a basis for the 
quantitative analysis of factors that potentially regulate mammalian gene expression. 
The backbone of the pGL3-Basic is designed for increased expression, and contains a 
modified coding region for firefly (Photinus pyralis) luciferase that has been 
optimized for monitoring transcriptional activity in transfected eukaryotic cells. This 
vector lacks eukaryotic promoter and enhancer sequences, allowing maximum 
flexibility in cloning putative regulatory sequences. Expression of luciferase activity 
in cells transfected with this plasmid depends on insertion and proper orientation of a 
functional promoter directionally upstream from luc+. pGL3-Basic Vector circle map 
is shown in figure 2.1 (Promega Technical Manual, E1751). 
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Figure 2.1 : pGL3-Basic Vector circle map (Promega Technical Manual, E1751). 
2.1.7.2. pRL-TK 
The pRL-TK Vector (Promega, E2241) is intended for use as an internal control 
reporter and may be used in combination with any experimental reporter vector to 
co-transfect mammalian cells. The vector contains a cDNA (Rluc) encoding Renilla 
luciferase, which was originally cloned from the marine organism Renilla reniformis. 
The pRL-TK Vector contains the herpes simplex virus thymidine kinase promoter to 
provide low to moderate levels of Renilla luciferase expression in co-transfected 
mammalian cells. Renilla luciferase is a 36 kDa monomeric protein that does not 
require post-translational modification for activity. Therefore, like firefly luciferase, 
the enzyme may function as a genetic reporter immediately following translation. 
pRL-TK Vector circle map is shown in figure 2.2 (Promega Technical Bulletin, 
E2241). 
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Figure 2.2 : pRL-TK Vector circle map (Promega Technical Bulletin, E2241). 
2.1.7.3. Plasmid Constructs 
Plasmid constructs used in the forced transcription factor experiments are generous 
gift of Assoc. Prof. Dr. Işıl Aksan Kurnaz. 
▪ pRSV-Elk-1-VP16, a constitutively active Elk-1 construct is a Rous sarcoma virus 
promoter-driven vector encoding full-length wild-type Elk-1 fused to residues 410–
490 of the VP16 C-terminal sequence (Price et al., 1995). 
▪ pcDNA3-mPEA3, was constructed by Kurnaz, I., in 2001 and  encodes full-length 
mouse PEA3.   
▪ pcDNA3-Elk-1, was constructed by Dolce, in 2000 and encodes full-lenght human 
wild-type Elk-1. 
2.1.8. Commercial Kits 
Commercial kits used in the study are shown in the table below. 
Table 2.1: Commercial kits used in the study 
Kit Supplier Company 
8 Lx Magtration Genomic DNA Kit Precision System Science 
QIAprep® Spin Miniprep plasmid 
purification kit  
Qiagen, 27106 
QIAquick PCR Purification Kit Qiagen, 28104 
QIAquick Gel Extraction Kit Qiagen, 28706 
Endofree Plasmid Maxi Kit Qiagen, 12362 
Bid Dye Terminator v 3.1 Cycle 
Sequencing Kit 
Applied Biosystems 
Dual-Luciferase Reporter Assay System Promega, E1910 
Transfast Transfection Reagent Promega, E2431 
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2.1.9. Equipments 
Equipments used in the study are shown in the table below. 
Table 2.2: Equipments used in the study 
Equipment Supplier Company 
DNA sequencer Applied Biosciences 3100 Avant 
Electrophoresis Gel System E-C Apparatus Corporation, EC250-90 
Minicel Primo 
Microcentrifuge Beckman Coultier 
pH Meter Mettler Toledo MP220 
Balance Precisa 620C SCS 
UVIPhoto MW Version 99.05 for 
Windows 95 & 98 
UVItec Ltd. 
UV Transilluminator Biorad UV Transilluminator 2000 
Vilber Lourmat 
Vortex Heidolph, Reaxtop 
Quick Spin Labnet International, C1301-230V 
Water Bath Memmert 
Elektro-mag M 96 KP 
CO2 Incubator Shel Lab 
Hemacytometer FisherLab Scientific, 0267110 
Light Microscope Olympus CH30 (USA) 
Luminometre Thermo, Fluoroskan Ascent FL 
Magnetic stirrer VELP scientifica 
Thermo Cycler Techne, TC-3000                            
Corbett Palm Cycler 
Spectrophotometer Shimadzu, UV-1601                      
Thermo Scientific NanoDropTM 1000 
Ice machine SCOTSMAN  AF10 
Centrifuge Beckman Coultier, Allegra 25R                    
Thermo EC, IECCL10 
High Pressure Steam Sterilizer Tomy 5X-700E 
Refrigerator (+4 oC) UĞUR Derin Dondurucu 
Deep Freezer (-20 oC) UĞUR Derin Dondurucu 
Ultra Low Temperature Freezer (-80 oC) New Brunswick Scientific 
Pure Water System UHQ USF Elga 
TKA Wasseraufbereitungssysteme 
Orbital Shaker Thermo Electron Corporation, Forma 
Thermomixer Eppendorf Thermomixer comfort 
Laminar air flow cabinets FASTER BH-EN 2003 
Automatic pipette Thermo EC, Finnpipette 
Pipettes Ependorff 10µl, 20µl, 100µl, 200µl, 1ml 
Thermo EC, Finnpipette 1ml 
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2.2. METHODS  
2.2.1. Promoter sequence analysis of KATNB1 gene 
KATNB1 gene is located on chromosome 16 seperated from its upstream gene 
CCDC135 by 4292 base pair (bp) that comprise a putative promoter region for 
KATNB1 gene. 1000 bp upstream of the transcription start site of KATNB1 gene 
was determined via University of California Santa Cruz Bioinformatic Genome 
Browser software using "Get Genomic Sequence Near Gene" tool (Url-3). The 
"Promoter/Upstream by XXX bases" option represents upstream bases from 
transcription start site. The promoter region is then considered predicted, by 
alignment of the mRNA versus genomic. An illustration of the program screen is 
given in figure 2.3.  
 
 
Figure 2.3: Illustraiton of Genome Browser software. 
 
2.2.2. Bioinformatic analysis of the promoter region 
The promoter site of KATNB1 was analysed for the presence of a functional TATA-
box, CAAT-box, CG boxes and CpG islands. Presence of TATA box, CAAT box 
and CG box motif was analysed via The   European   Bioinformatics   Institute (EBI)    
Clustalw sequence analysis tool (Url-4). CpG island analysis is done through EBI, 
European Molecular Biology Open Software Suite, EMBOSS CpGPlot/Report tools 
(Url-5). 
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2.2.3. Deletion constructs determination 
Identifying genomic locations of transcription-factor binding sites, particularly in 
higher eukaryotic genomes, has been an enormous challenge. Various experimental 
and computational approaches have been used to detect these sites; methods 
involving computational comparisons of related genomes have been particularly 
successful. To predict possible protein-DNA interaction, the promoter region of 
KATNB1 gene was analysed via TRANSFAC® 7.0 Public 2005                                
(Matys et al., 2006), available online at this web adress: http://www.gene-
regulation.com/pub/databases.html. This database contains data on transcription 
factors, their experimentelly-proven binding sites, and regulated genes. Deletion 
constructs were determined by reasonably seperating the transcription factor binding 
site in a meaningful way.  
2.2.4. DNA Isolation from whole blood 
The DNA isolation was performed using Migration System 8Lx Instrument. DNA 
isolation kits were supplied by Precision System Science. DNA was isolated in an 
automated system and nearly 4 ml of blood was used. Isolated DNA was kept at         
-20°C then DNA was diluted 1:100 ratio with sterile dH2O to a total volume of 500µl 
and absorbance values at 260nm, 280nm, and 320nm were measured. Concentration 
and DNA quality calculations from absorbance values are done according to the 
equations 2.1 and 2.2. 
DNA Concentration (ng/µl) = (A260 - A320) x Dilution Factor                            (2.1) 
DNA Quality = (A260 – A320) / (A280 – A320)                                                   (2.2) 
To obtain the working aliquots, stock DNA was diluted to 50ng/µl with sterile dH2O. 
2.2.5. Primer Design 
Forward and reverse primers specific for each deletion construct with appropriate 
flanking restriction site were designed by considering the general rules of primer    
design using Integrated DNA Technologies, Oligo Analyser 3.1 tool (Url-6). For 
forward primers KpnI enzyme restriction site shown in green in table 2.3 were added 
to the 5’end of the primers and for reverse primer HindIII enzyme restriction site 
shown in blue in table 2.3 were added to the 5’end of the primer. The upstream 
stretches of adenine residues shown in red were added to allow proper restriction 
enzyme cutting. GC content, self-hybridization, hetero-dimer formation between 
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primer pairs, hairpin formation and presence of secondary priming sites was taken 
into consideration while choosing the appropriate primer pairs. All the primers used 
in the study including amplification primers and pGL3-Basic sequencing primers are 
given in table 2.3. 
Table 2.3: Primers used in the study 
Primer Name Primer sequence (5’ 3’) Tm % G/C Length 
Katnb1_F1 AAAAGGTACCTCATCTGTAAATGGGAACAGGAATT 60.8°C 37.1 35 
Katnb1 _F2 AAAAGGTACCATCTGCAGGCAAAGTGAA 60.6°C 42.9 28 
Katnb1 _F3 AAAAGGTACCACACAAATTAGGTTCGAGGG 60.3°C 43.3 30 
Katnb1 _F4 AAAAGGTACCGAGGCGGGACT A 60°C 54.5 22 
Katnb1 _F5 AAAAGGTACCTTCCTTCCTCTTGATTAGTCCTATTT 60°C 36.1 36 
Katnb1_R AAAAAAGCTTACCTCCGGCTCAGAGC 61.1°C 50 26 
Katnb1_F6_F CGGGCGGGGCTCTGAGCCGGAGGTA 71.8°C - 25 
Katnb1_F6_R AGCTTACCTCCGGCTCAGAGCCCCGCCCGGTAC - - 33 
Katnb1_F7_F CCTCTGAGCCGGAGGTA 53.4°C - 17 
Katnb1_F7_R AGCTTACCTCC GGCTCAGAGGGTAC - - 25 
pGL3_F TGTCCCCAGTGCAAGTG 55,1°C 58,8 17 
pGL3_R CTTTCTTTATGTTTTTGGCGTCTTCCA 56,4°C 37 27 
2.2.6. Amplification of KATNB1 constructs 
Polymerase Chain Reaction is used to amplify a fragment from template DNA 
sequence. Borders of amplified fragments are defined with small oligonuclotides 
named primers. These primers provide a binding site on template DNA for DNA 
polymerases. The buffers are used to preserve DNA polymerase in its natural 
confirmation and dNTP molecules are included to the reaction mixture to be 
integrated into newly forming DNA molecules. 
2.2.6.1. PCR of KATNB1 1000bp promoter 
For amplification of 1000 bp promoter region of KATNB1 gene following PCR 
reaction and PCR program was applied. The denaturation time was extended to 20 
minutes (min) in order to efficiently denature the template which was genomic DNA. 
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Table 2.4 : PCR Reaction for cloning KATNB1 1000bp promoter 
Stock 
Concentrations
PCR Ingredients 1X Final 
Concentration
10X Taq
 Buffer without Mg 5 µl 1X
2 mM dNTP Mix 4 µl 0,16 µM
10 µM Forward Primer 2 µl 0,4µM
10 µM Reverse Primer 2 µl 0,4 µM
50ng/µL Genomic DNA 2 µl 2 ng/µL
5U/µL Taq
 DNA Polymerase 0.5 µl 0.05 U/µL
25 mM MgCl2 2 µl 1 mM
dH2O 32,5µl
TOTAL 50 µl
 
Table 2.5 : PCR program for cloning KATNB1 1000bp promoter 
Steps Cycles Temperature Time
Initial denaturation 1 95°C 20 min
Denaturation 95°C 45 sec
Annealing 35 60°C 45 sec
Extension 72°C 1 min
Final Extension 1 72°C 5 min
Hold - 4°C ∞
 
2.2.6.2. PCR of KATNB1 deletion constructs 
For amplification of 4 deletion constructs of 1000 bp promoter region of KATNB1 
gene following PCR reaction and PCR program was applied. The template used in 
those PCR was the first cloned 1000 bp promoter vector. Appropriate primer pairs 
having each the same melting temperature (60 °C) were used for each PCR. 
Table 2.6: PCR Reaction for cloning KATNB1 deletion constructs 
Stock 
Concentration
PCR Ingredients 1X Final 
Concentration
10X Taq
 Buffer without Mg 5 µl 1X
2 mM dNTP Mix 4 µl 0,16 µM
10 µM Forward Primer 2 µl 0,4µM
10 µM Reverse Primer 2 µl 0,4 µM
- pGL3-Basic-F1 2 µl -
5U/µL Taq
 DNA Polymerase 0.5 µl 0.05 U/µL
25 mM MgCl2 2 µl 1 mM
dH2O 32,5µl
TOTAL 50 µl
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Table 2.7: PCR program for cloning KATNB1 deletion constructs 
Steps Cycles Temperature Time
Initial denaturation 1 95°C 5 min
Denaturation 95°C 45 sec
Annealing 35 60°C 45 sec
Extension 72°C 1 min
Final Extension 1 72°C 5 min
Hold - 4°C ∞
 
2.2.6.3. Hybridization of KATNB1 short constructs 
Since the 2 last constructs that wanted to be amplified were composed of very short 
oligonucleotide strands, it was not easily possible to amplify them with PCR. For that 
reason those sequences were designed as primer pairs and were annealed in 
thermocycler by decreasing the temperature gradually. The goal here was to denature 
the complementary strands to remove any secondary structures present and then 
allow the strands to hybridize. For the hybridization procedure, 10 µl of each primer 
pair from 100mM stock solutions was mixed together at a 1:1 molar ratio in a PCR 
tube. The PCR program used in the hybridization of the longer insert is shown in 
Table 2.8 and the program used in the hybridization of the shorter insert is shown in 
Table 2.9. 
Table 2.8.: Hybridization program for KATNB1 longer construct 
Steps Cycles Temperature Time
Step 1 1 95°C 5 min
Step 2 11* 95°C (-2°C /cycle) 1 min
Step 3 1 72°C 30 min
Step 4 34* 72°C (-2°C /cycle) 1 min
Step 5 - 4°C ∞
 
*The number of cycles in Step 2 and 4 depends on the Tm of the oligonucleotides. 
Table 2.9: Hybridization program for KATNB1 shorter construct 
Steps Cycles Temperature Time
Step 1 1 95°C 5 min
Step 2 20* 95°C (-2°C /cycle) 1 min
Step 3 1 54°C 30 min
Step 4 25* 54°C (-2°C /cycle) 1 min
Step 5 - 4°C ∞
 
*The number of cycles in Step 2 and 4 depends on the Tm of the oligonucleotides. 
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2.2.7. Agarose gel electrophoresis for detection of PCR amplification 
The expected DNA fragment length after PCR amplification was about 1000 bp 
which is estimated to be clearly detectible in 1% agarose gel. To prepare 1% agarose 
gel in a mini electrophoresis system, 0.5 g agarose was dissolved in 50 µl 1X TAE 
buffer. 0.5 µg/mL ethidium bromide concentration was used for the gel. For each 
sample, 5 µl of PCR amplicon was mixed by 1 µl of 6X loading dye. As a standard, 
MassRuler™ DNA Ladder Mix was used to estimate the PCR amplicon size. 
Electrophoresis conditions were 40 minutes at 120V (12V/cm of gel). Pictures of the 
gels were taken under UV light with a transilluminator, by the help of UV PhotoMW 
software. 
2.2.8. Purification of PCR products 
After PCR, the fragments were purified with Qiagen QIAquick PCR Purification Kit. 
This kit removes the protein contamination derived from polymerase enzymes. The 
principle of the kit is given as followed, DNA is bound to glass fleece with aid of 
high concentrated choatropic salt, remains of protein are removed with washes, 
finally the DNA molecules are released with low salt concentration elution buffer. 
The purification protocol is given below: 
• Total volume of PCR product was brought to 100 µl and 500 µl Binding Buffer  
(3 M guanidine-thiocyanate, 10 mM Tris-HCl, 5% ethanol (v/v), 2 mg RNase) 
was added to each PCR tube. 
• After mixing the sample well, sample was transferred into collection filter tubes 
and centrifuged 1 minute at 14000 rpm at table top centrifuge. 
• Flow through was discarded and 500 µl Wash buffer (20 mM NaCl, 2 mM Tris-
HCl, 80% ethanol) was added. Then again, the filter tube was centrifuged at 
14000 rpm for 1 minute. 
• Flow through was discarded and the filter tube was centrifuged at 14000 rpm for 
1 minute to remove the residual wash buffer. 
• The filter was connected to a clean 1.5 ml eppendorf tube. And 50 µl of Elution 
buffer (10 mM Tris-HCl, pH 8.5) was added then it was centrifuged at 14000 
rpm for 1 minute. 
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2.2.9. Restriction enzyme digestion of PCR products and the vector 
DNA fragments are cut with sticky end restriction enzymes forming nicks in the 
structure of DNA, this phenomenon serves for generating sticky overhangs which 
have the ability to complement with a fragment containing the same overhang. 
Purified fragment and target vector pGL3-Basic were double digested with 
FastDigest Hind III and KpnI restriction enzymes that would generate compatible 
ends for cloning. Restriction digestion mix was prepared according to the table 2.10. 
Table 2.10: Restriction mix for HindIII and KpnI double digestion 
Ingredients Amount Final 
Concentration
10X Fast Digest Buffer 5 µl 1X
FastDigest Hind III 2 µl 0.5U/µl
FastDigest Kpn I 2 µl 0.5U/µl
PCR Amplicon/ pGL3 20 µl -
dH2O 21 µl -
TOTAL 50 µl
 
Restriction enzyme digestion was performed at 37°C for 1 hour (h) and followed by 
10 minute incubation at 80°C for the inactivation of restriction enzymes. 
2.2.10. Determination of restriction pattern by agarose gel electrophoresis 
Digested samples were run on 1% agarose gel. For each PCR sample, 5 µl of 
amplicon was mixed by 1 µl of 6X loading dye. As a standard, MassRuler™ DNA 
Ladder Mix was used to estimate the PCR amplicon size. Electrophoresis conditions 
were 40 minutes at 120V (12V/cm of gel). Pictures of the gels were taken under UV 
light with a transilluminator, by the help of UV PhotoMW software. 
2.2.11. Purification of digested PCR products and vector 
Purification of the digested PCR products were performed with Qiagen QIAquick 
PCR Purification Kit as described in section 2.2.8.  The digested vector was purified 
from the agarose gel via QIAquick Gel Extraction Kit. The purification protocol is 
given below: 
• Gel slice containing the DNA band was excised with a clean, sharp scalpel. 
• After weighing the gel slice in a colorless tube, 3 volumes of Buffer QG was 
added to 1 volume of gel.  
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• The tube was incubated at 50°C for 10 min. To help dissolve gel, the tube was 
mixed by vortexing every 2–3 min during the incubation. 
• 1 gel volume of isopropanol was added to the sample and mixed. 
• A QIAquick spin column was placed in a provided 2 ml collection tube. 
• The sample was applied to the QIAquick column and centrifuged for 1 minute at 
14000 rpm at table top centrifuge. 
• Flow-through was discarded and the column was placed back in the same 
collection tube. 
• 0.5 ml of Buffer QG was added to the column and centrifuged for 1 minute at 
14000 rpm. 
• To wash, 0.75 ml of Buffer PE was added to the column and centrifuged for 1 
minute at 14000 rpm. 
• Flow-through was discarded and the column was centrifuged for an additional 1 
minute at 14000 rpm. 
• The column was placed into a clean 1.5 ml microcentrifuge tube. 
• To elute DNA, 50 µl of Buffer EB (10mM Tris-HCl, pH 8.5) was addad to the 
center of the QIAquick membrane and after waiting for 1 minute the column was 
centrifuged for 1 minute at 14000 rpm. 
2.2.12. Ligation of deletion constucts into pGL3-Basic vector 
Purified vector and insert gene were ligated with Roche T4 ligase according to 2:15 
molecular ratio. The ligation reaction mixture is given table 2.11. 
Table 2.11 : Ligation mixture of pGL3-Basic and deletion constructs 
Ingredients Amount
Insert 7 µl
pGL3- Basic 1 µl
10X Roche T4 ligation buffer 1 µl
Roche T4 Ligase 1 µl
  Total 10 µl
 
Ligation mixture was prepared according to table and ligation was performed at 
room temperature (RT) overnight. Ligation inactivation is performed by heating the 
samples in thermal cycler to 65 °C for 5 minutes.  
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2.2.13. Transformation of Constructed pGL3 Basic-insert plasmid 
Subsequent to ligation, plasmid constructs were transformed into a bacterium host in 
order to increase the number of plasmids. Bacterial cells are amenable to modify in 
order to intake DNA. For this approach; first, the cell wall is disrupted with CaCl2 
and later, DNA binds to disrupted cell wall fractions and finally, DNA is introduced 
into cell with membrane scaring by heat shock. In our lab, CaCl2 treatment based 
chemical competent cells are used. Escherichia coli (E. coli) DH5α were modified 
into competent cells. The chemical competent cell preparation protocol (Sambrook 
and  Russell, 2001) is given below: 
• LB plate was streaked with DH5α frozen stock. 
• One good separated colony was chosen for inoculation of 3 ml liquid LB media. 
Media was incubated at 37 °C with 250 rpm shaking overnight (~16 hours). 
• 100 ml LB medium was inoculated with overnight culture, and incubated at 37 
°C with 250 rpm shaking for 2.5-3 hours until OD590 reaches 0.612. 
• Culture was taken into 2 pre-chilled sterile 50 ml falcons and placed on ice for 10 
minutes. 
• Vials were centrifuged at 2500 rpm for 5 minutes at 4 °C. Supernatant was 
discarded. 
• Each pellet was washed with 10 ml ice cold CaCl2 solution, and then centrifuged 
at 2500 rpm for 5 minutes at 4 °C. 
• Pellets were resuspended with 2 ml ice cold CaCl2 solution and 25 µl of 
resuspension aliquoted into pre-chilled 1.5 ml eppendorf tubes. Aliquots were 
frozen with liquid nitrogen and stored at -80 °C. 
And heat shock transformation was applied accordingly: 
• 25 µl aliquots were taken from -80 °C, and thawed on ice. 
• 1 µg DNA was added to each vial and left on ice for 30 minutes. 
• The vial was placed in 42 °C water bath for 45 seconds and put on ice for 2-3 
minutes. 
• 80 µl of SOC medium was added, and then culture was incubated at 37 °C for 1 h 
shaking at 250 rpm. 
• Cultures were plated on selective medium with appropriate antibiotic (LB-Amp) 
• Plates were incubated upside down at 37 °C overnight. 
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2.2.14. Colony PCR of transformed colonies  
Colony PCR is a specified PCR technique allowing to check if the colonies contain 
the plasmid of interest. Selected colonies were streaked onto new LB-Amp plates and 
incubated at 37°C overnight. After the colonies emerged, colony PCR was executed 
with pGL3 sequencing primers. Procedure of the colony PCR is given below: 
• 10 µl of sterile dH2O was added to adequate number of PCR tubes, and a tip of 
each colony was resuspended.    
• Mixture was incubated in thermal cycler at 85°C for 15 minutes. 
• The mixture was vortexed and centrifuged. 
• Supernatant of the mixture was employed as sample to PCR reaction given 
below: 
Table 2.12 : Colony PCR reaction 
Stock Concentration PCR Ingredients 1X Final Concentration
10X Taq
 Buffer without Mg 2.5 µl 1X
2 mM dNTP Mix 2 µl 0.16 mM
10 µM pGL3 Forward Primer 1 µl 0.4 mM
10 µM pGL3 Reverse Primer 1 µl 0.4 mM
- Colony water mix 10 µl -
5u/µL Taq
 DNA Polymerase 0.25 µl 1.25 unit
25 mM MgCl2 1.5 µl 1.5 mM
- dH2O 6.75 µl -
TOTAL 25 µl
 
 
Table 2.13 : Colony PCR program 
Steps Cycles Temperature Time
Initial denaturation 1 95°C 5 min
Denaturation 95°C 30 sec
Annealing 35 50°C 30 sec
Extension 72°C 1 min
Final Extension 1 72°C 5 min
Hold - 4°C ∞
 
The resultant PCR products were run on 1% TAE Agarose gel and insert containing 
colonies were selected.  
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2.2.15 DNA isolation 
DNA was isolated from colony PCR positive colonies with Qiaprep Spin Miniprep 
Plasmid Isolation Kit. The procedure is given below: 
• 5 ml of LB was inoculated with positive colony and the culture was incubated at 
37 °C with 250 rpm shaking overnight. 
• Overnight cultures were centrifuged at 5000 rpm for 5 minutes. Supernatant was 
discarded and pellet was resuspended in 250 µl Buffer P1 (50 mM Tris-Cl, pH 
8.0; 10 mM EDTA; 100 µg/ml RNase A) and transfered to a microcentrifuge 
tube. 
• 250 µl Buffer P2 (200 mM NaOH, 1% SDS (w/v)) was added and mixed 
thoroughly by inverting the tube 4–6 times. 
• 350 µl pre-chilled Buffer N3 (3.0 M potassium acetate, pH 5.5) was added and 
mixed immediately and thoroughly by inverting the tube 4–6 times. 
• Suspension was centrifuged for 10 minutes at 14,000 rpm in a table-top 
microcentrifuge. 
• The supernatant from previous step was applied to the QIAprep spin column by 
pipetting. 
• Filter-tube assambly was centrifuged for 30–60 seconds. The flow-through was 
discarded. 
• The QIAprep spin column was washed by adding 0.5 ml Buffer PB (5 M Gu-
HCl, 30% ethanol) and centrifuging for 30–60 seconds. Flow-through was 
discarded. 
• The QIAprep spin column was washed by adding 0.75 ml Buffer PE (10 mM 
Tris-HCl, pH 7.5; 80% ethanol) and centrifuging for 30–60 seconds. 
• The flow-through was discarded, and tubes were centrifuged for an additional 1 
minute to remove residual wash buffer. 
• QIAprep column was placed in a clean 1.5 ml microcentrifuge tube. To elute 
DNA, 50 µl Buffer EB (10 mM Tris-HCl, pH 8.5) was added to the center of 
each QIAprep spin column. Column was let standing for 1 minute, and 
centrifuged for 1 minute. 
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2.2.16 Sequencing  
DNA sequencing is the process of determining the nucleotide order of a given DNA 
fragment. For sequencing dye terminator sequencing was performed. This is 
accomplished by using different fluorescent dye labelled dideoxynucleotide chain-
terminators, which fluoresce at a different wavelength. 
2.2.16.1. Sequencing PCR 
Sequencing PCR is special kind of PCR in which single strand of DNA is amplified. 
Each dNTP is labeled with different fluorescent tag; therefore, resultant DNA 
fragment is fluorescently labeled. Single strand of DNA is desired to be exploited 
since 2 strands apparently interfere the fluorescence of each other. Thus, only one 
primer is used in sequencing PCR. The reaction is performed in dark in order to 
preserve fluorescence. The reaction mixture preparation is given in the table below: 
Table 2.14: Sequencing PCR ingredients 
Stock 
Concentration
PCR Ingredients 1X Final 
Concentration
- Big Dye Terminator 2µl -
5X Sequencing Buffer 2µl 1X
10 mM pGL3_F/ pGL3_R 1µl 1 mM
- Plasmid 1µl -
- dH2O 4µl -
Total 10µl
 
Table 2.15: Sequence PCR program 
Steps Cycles Temperature Time
Initial denaturation 1 95°C 5 min
Denaturation 95°C 45 sec
Annealing 40 50°C 45 sec
Extension 60°C 4 min
Hold - 4°C ∞
 
2.2.16.2. PCR Product Purification for Sequencing 
Since PCR product was contaminated with polymerase, a subsequent purification 
was performed. All the purification steps are performed in dark in order to preserve 
fluorescence. The protocol is as follows:  
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• 10 µl PCR product was taken in to microfuge tube then 2 µl of 3M NaAc and 
50 µl ice-cold 95% ethanol were added to tube. 
• Tubes were incubated on ice for 30 minutes. 
• Mixture was centrifuged at 14000 rpm for 30 minutes. Supernatant was 
discarded and pellet was resuspended by vigorourisly vortexing the sample in 
200 µl ice-cold %70 ethanol. 
• Tubes were centrifuged at 14000 rpm for 15 minutes. Supernatant was 
discarded. 
• Tubes were incubated with caps open at 95°C for 5 minutes in order to 
evaporate residual ethanol. 
• 20 µl of Hi-Di formamide was added to DNA pellet and the mixture was 
vortexed vigorously and then spun down. 
• Tubes were again incubated at 95 °C for 5 minutes with caps closed. 
• Tubes were immediately put on ice and kept at 4 °C until analysis. 
2.2.16.3. Analysis of Sequence Results 
Analysis of sequence results was performed via EBI Clustalw sequence analysis tool 
(Url-4).  ClustalW2 is a general purpose multiple sequence alignment program for 
DNA or proteins. It produces biologically meaningful multiple sequence alignments 
of divergent sequences. It calculates the best match for the selected sequences, and 
lines them up so that the identities, similarities and differences can be seen. 
2.2.17. Large scale plasmid production 
After confirming the sequence data and assuring that none of the constructs possess 
any mutations, each construct was transformed with E.coli dam-/dcm- GM2163 
strain in order to prevent any methylation that can interfere the transcription factor 
binding, according to the previously described heat shock transformation in section 
2.2.12. After the colonies emerged the insert containing plasmids was reproduced in 
large scale and purified with QIAGEN, EndoFree® Plasmid Maxi kit. This kit is 
chosen because subsequent to large scale production the plasmids are going to be 
used to transfect SHSY-5Y neuroblastoma cell line which is a sensitive cell line. 
Endotoxins, which are cell membrane components of Gram-negative bacteria (E.coli) 
strongly influence transfection and increased endotoxin levels lead to sharply 
reduced transfection efficiencies. Plasmid isolation procedure is as follows: 
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• 5 ml of LB was inoculated with positive colony and the culture was incubated at 
37 °C with 250 rpm shaking for 8 h. 
• 100 ml LB medium with appropriate antibiotic was inoculated with 100 µl of 
starter culture and grown at 37°C for 12–16 h with vigorous shaking.  
• Overnight cultures were centrifuged at 4100 rpm for 90 min. 
• Supernatant was discarded and pellet was resuspended in 10 ml Buffer P1 (50 
mM Tris·Cl, pH 8.0; 10 mM EDTA; 100 µg/ml RNase A) and transfered to a 50 
ml centrifuge tube. 
• 10 ml Buffer P2 (200 mM NaOH, 1% SDS (w/v)) was added and mixed 
thoroughly by inverting the tube 4–6 times and incubated at RT for 5 min. 
• 10 ml pre-chilled Buffer N3 (3.0 M potassium acetate, pH 5.5) was added and 
mixed immediately and thoroughly by inverting the tube 4–6 times. 
• Lysate was poured into the barrel of the QIAfilter Cartridge and incubated at 
room temperature for 10 min then the lysate was filtered into a 50 ml tube. 
• 2.5 ml Endotoxin removal buffer (ER) was added to the filtered lysate, and mixed 
by inverting the tube approximately 10 times, and incubated on ice for 30 min. 
• During the incubation QIAGEN-tip 500 was equilibrated by applying 10 ml 
Buffer QBT (750 mM NaCl; 50 mM MOPS, pH 7.0; 15% isopropanol (v/v); 
0.15% Triton® X-100 (v/v)) and the column was allowed to empty by gravity 
flow. 
• The filtered lysate was applied to the QIAGEN-tip and allowed to enter the resin 
by gravity flow. 
• QIAGEN-tip was washed with 2 x 30 ml Buffer QC (1.0 M NaCl; 50 mM 
MOPS, pH 7.0; 15% isopropanol (v/v)). 
• DNA was eluted with 15 ml Buffer QN (1.6 M NaCl; 50 mM MOPS, pH 7.0; 
15% isopropanol (v/v)). 
• DNA was precipitated by adding 10.5 ml room-temperature isopropanol to the 
eluted DNA and centifuged immediately at 4100 rpm for 2 h at 4°C. 
•  After carefully decanting the supernatant DNA pellet was washed with 5 ml of 
endotoxin-free room-temperature 70% and centrifuge at a at 4100 rpm for 2 h at 
4°C. 
• The supernatant was carefully decanted without disturbing the pellet. 
• The pellet was air-dried for 5–10 min, and the DNA was redissolved in 300 µl 
endotoxin-free Buffer TE (10 mM Tris-Cl, pH 8.0; 1 mM EDTA). 
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2.2.18 Transfection of SH-SY5Y with F2 deletion construct plasmid and ELK-1, 
ELK-1-VP16 and PEA3 constructs for forced experiments 
Transfection is the process to introduce a foreign DNA into the cell. There are 
various methods of introducing foreign DNA into an eukaryotic cell. Many materials 
like (cationic) polymers, liposomes, nanoparticles have been used as carriers for 
transfection and different methods are developed including electroporation, viral 
infection, lipofection, gene guns and microinjection. For eukaryotic cells, lipid-cation 
based transfection is more typically used, because the cells are more sensitive. In this 
study, DNA was inserted into SH-SY5Y neuroblastoma cells by lipofection. 
Basically synthetic cationic lipids that can form liposomes are incubated with DNA. 
These liposomes spontaneously interact with DNA and fuse with tissue culture cells. 
Incubation of cationic lipid-containing liposomes and nucleic acids results in quick 
association and a compaction of the nucleic acid presumably from electrostatic 
interactions between the negatively charged nucleic acid and the positively charged 
head group of the synthetic lipid. The liposome/nucleic acid complex is then 
presented to the cells that are to be transfected. The liposome complex neutralizes the 
negative charge of the nucleic acids, allowing closer association of the complex with 
the negatively charged cell membrane. Entry of the liposome complex into the cell 
may occur by the processes of endocytosis or fusion with the plasma membrane via 
the lipid moieties of the liposome. Transfection mixture contents are given in tables 
2.16, 2.17, 2.18 and 2.19 and the transfection procedure is as follows:  
• A frozen stock of SHSY-5Y cells were taken from -80 °C and after the cells 
warmed up to room temperature they were diluted with SHSY-5Y culture media 
which’s content was given in section 2.1.6.6. 
• After determining the cell density with hemacytometer, 50.000 cells per well 
were seeded on 24 well tissue culture plate one day before the transfection 
experiment so that the cells were approximately 80% confluent on the day of the 
transfection.  
• 1 µg of plasmid DNAs are diluted in 200 µl DMEM (1X) Media and vortexed 
and quick spun briefly. 
• Promega’s transfection reagent Transfast was added to 1:3 ratio to the DNA 
mixture according to the ratios given in the table below and vortexed and quick 
spun briefly for the proper formation of DNA liposome complex and incubated 
for 15 minutes at room temperature. 
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Table 2.16: Transfection mixture contents for deletion constructs transfections 
Deletion 
Construct name 
pGL3 
Test Construct 
pRL-TK 
Contol Construct 
Total DNA 
(µg) 
Transfast 
Reagent 
pGL3_F1 900 ng 100 ng 1 µg 3 µl 
pGL3_F2 900 ng 100 ng 1 µg 3 µl 
pGL3_F3 900 ng 100 ng 1 µg 3 µl 
pGL3_F4 900 ng 100 ng 1 µg 3 µl 
pGL3_F5 900 ng 100 ng 1 µg 3 µl 
pGL3_F6 900 ng 100 ng 1 µg 3 µl 
pGL3_F7 900 ng 100 ng 1 µg 3 µl 
pGL3_Basic 900 ng 100 ng 1 µg 3 µl 
*Each transfection was performed as triplicates. 
Table 2.17: Transfection mixture contents for ELK-1 forced experiment transfections 
Deletion 
Construct name 
pGL3 
Test 
Construct 
ELK-1 
Construct 
pCMV-
Myc 
Construct 
pRL-TK 
Contol 
Construct 
Total 
DNA 
(µg) 
Transfast 
Reagent 
pGL3_F2_Elk1 700 ng 200ng - 100 ng 1 µg 3 µl 
pGL3_Basic_Elk1 700 ng 200ng - 100 ng 1 µg 3 µl 
pGL3_F2 700 ng - 200ng 100 ng 1 µg 3 µl 
pGL3_Basic 700 ng - 200ng 100 ng 1 µg 3 µl 
*Each transfection was performed as triplicates. 
Table 2.18: Transfection mixture contents for ELK-1-VP16 forced experiment transfections 
Deletion 
Construct name 
pGL3 
Test 
Construct 
ELK-1- 
VP-16 
Construct 
pCMV-
Myc 
Construct 
pRL-TK 
Contol 
Construct 
Total 
DNA 
(µg) 
Transfast 
Reagent 
pGL3_F2_Elk1VP16 700 ng 200ng - 100 ng 1 µg 3 µl 
pGL3_Basic_Elk1VP16 700 ng 200ng - 100 ng 1 µg 3 µl 
pGL3_F2 700 ng - 200ng 100 ng 1 µg 3 µl 
pGL3_Basic 700 ng - 200ng 100 ng 1 µg 3 µl 
*Each transfection was performed as triplicates. 
Table 2.19: Transfection mixture contents for PEA3 forced experiment transfections 
Deletion 
Construct name 
pGL3 
Test 
Construct 
PEA3 
Construct 
pCMV-
Myc 
Construct 
pRL-TK 
Contol 
Construct 
Total 
DNA 
(µg) 
Transfast 
Reagent 
pGL3_F2_PEA3 700 ng 200ng - 100 ng 1 µg 3 µl 
pGL3_Basic_PEA3 700 ng 200ng - 100 ng 1 µg 3 µl 
pGL3_F2 700 ng - 200ng 100 ng 1 µg 3 µl 
pGL3_Basic 700 ng - 200ng 100 ng 1 µg 3 µl 
*Each transfection was performed as triplicates. 
 
• The growth medium was removed from the cells and the transfection mixture 
was added gently in order to prevent cell detaching and the cells returned to the 
37°C %5 C02 incubator. 
• After an incubation period of 90 minutes, the transfection mixture was removed 
and 500 µl of complete growth medium of which the content was given in the 
section 2.1.6.6 was added to each well. 
• The cells were returned to the 37°C %5 C02 incubator for 48 hours before 
analysis. 
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2.2.19. Luminometrical measurement of the transfected cells  
Genetic reporter systems are widely used to study eukaryotic gene expression. Dual 
reporters are commonly used to improve experimental accuracy. Normalizing the 
activity of the experimental reporter to the activity of the internal control minimizes 
experimental variability caused by differences in cell viability or transfection 
efficiency. Other sources of variability, such as differences in pipetting volumes, cell 
lysis efficiency and assay efficiency, can be effectively eliminated. In this study, the 
Dual-Luciferase® Reporter (DLR) Assay System from Promega was used. In the 
DLR Assay, the activities of firefly (Photinus pyralis) and Renilla (Renilla 
reniformis) luciferases are measured sequentially from a single sample. To perform 
the assay, at first cells are harvested by lysing them with 1X Passive Lysis Buffer. 
This buffer is specifically formulated to minimize the low-level autoluminescence 
emitted by the Renilla luciferase substrate, coelenterazine. The firefly luciferase 
reporter is measured first by adding Luciferase Assay Reagent II (LAR II) to 
generate a stabilized luminescent signal. After quantifying the firefly luminescence, 
this reaction is quenched, and the Renilla luciferase reaction is simultaneously 
initiated by adding Stop & Glo® Reagent to the same tube. The Stop & Glo® 
Reagent also produces a stabilized signal from the Renilla luciferase, which decays 
slowly over the course of the measurement (Promega Technical Manual, E1910).  
Expression of luciferase activity in cells transfected with plasmids containing 
different regions of KATNB1 gene promoter depends on the functionality of the 
promoter upstream from luc+. For the forced experiments, the expression of 
luciferase activity in cells transfected with plasmids cotaining different regions of 
KATNB1 gene and with the transcription factors expressing vectors depends on the 
functionality of the transcription factor on the promoter upstream from luc+.  
The chemiluminescence was measured by Fluoroskan Ascent FL luminometre from 
Thermo Electron Coorporation. The PMT voltage was the default setting which is 
845 and integration time was chosen to be 10000. Scaling factor was adjusted to 10 
after optimization the measurements. At least 1 h before the assay needed amount of 
the Luciferase assay Reagent and Stop & Glo® Buffer were taken out from -80°C 
and -20°C refrigerators respectively to be thawed in room temperature water bath. 
After the reagents have thawed to room temperature, the Stop & Glo® Reagent was 
prepared by adding 50X Stop & Glo® Substrate to the Stop & Glo® Buffer to 1X 
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final concentration. All transfections were performed as triplicates and were repeated 
at least two times using different DNA preperations. Cells were prepared to the assay 
according to the manufacturer instructions, 
• 48 hours post-transfection, growth medium was removed from the cultured cells, 
and 60 µl 1X passive lysis buffer was added to each well. 
• Homogeneous lysates was rapidly prepared by manually scraping the cells. 
• The lysates were transfered into microfuge tubes for further analysis.  
• Luminometer was programmed to perform a 2-second premeasurement delay 
while shaking the plate, followed by a 10-second measurement period for each 
reporter assay. 
• 50 µl of LAR II was predispensed into one well of luminometer plate and then  
50 µl of cell lysate was transferred to the same well. 
• Firefly luciferase luminescence was measured and recorded. 
• 50 µl of Stop & Glo® Reagent was added to the same well. 
• Renilla luciferase luminescence was measured and recorded. 
• The procedure was repeated for each sample separetly. 
 
2.2.20. Evaluation of the luminometrical measurement data of promoter 
deletion constructs 
In order to evaluate the luminometrical measurments data, PROMO bioinformatic 
tool from ALLGEN server, available online at this web adress: 
http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/promoinit.cgi?dirDB=TF_8.3 was 
used (Messeguer et al., 2002, Farre et al., 2003). PROMO is a virtual laboratory 
allowing the study of transcription factor binding sites in DNA sequences from a 
species or group of species of interest. Transcription factor binding sites defined in 
the TRANSFAC database (Matys et al., 2006),  are used to construct specific binding 
site weight matrices for transcription factor binding sites perdiction. The search for 
KATNB1 promoter was done by selecting factor’s species as Homo sapiens and site 
species as Homo sapiens and by restriction the search maximum matrix dissimilarity 
rate as 5% and also by selecting factor’s species as eutheria and site species as 
eutheria and by restriction the search maximum matrix dissimilarity rate as 5%. 
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3. RESULTS  
3.1. Promoter sequence analysis of KATNB1 gene 
Putative KATNB1 gene promoter is located on chromosome 16 between CCDC135 
and KATNB1 genes according to NCBI Map Viewer database (Url-7). This 4292 bp 
region comprise the promoter region of KATNB1 gene. The sequence data of this 
region is given in Appendix B. Sequence data of 1000 base pair promoter (F1) 
determined via University of California Santa Cruz Bioinformatic Genome Browser 
software is given in table 3.1. 
Table 3.1 : Sequence data of 1000 base pair promoter (F1) 
TCATCTGTAAATGGGAACAGGAATTCCTACCTCTTATGGTTGTACTGGGC 
GTTATGTGAGCCCAAGGAGCCCTGACCTGCGGTGAGAGGCTGGAGGCCGA 
AGGGCAAGGTTCGAGGGGCTCTGGGTGCCTGGGACAACCTCTGGGCAACA 
GGGAGAGGCGGCTGCGGGGCCAAGTCCCTCCTAAGCGGCCACGCGAGAGG 
CCCTGAGTCGAGAAGGGTTACGGCGCTTCCCAGAGCCCACCCCGCCCAAC 
GTGTCACAAATAAAGCTGGCCTTTCTCCGATTCCCTGATTGCAGCCATTC 
AGGGAGCAGCCCCTTGCCCACGCATCCATTAGTCGAGGCGGTGGCTGCGT 
GTGCAGTGCTACAGGGTTCAGCGCCTGCCTCGGCTCCGGAATCAGGCTGT 
TTCCTTCTAGACCTCCCATGGGGGATTCAAGCCGGCGTCCGGGTCAAAGA 
ACAGGGACAAAGTCCTCCTGCCACGGGGGACCATCTGCAGGCAAAGTGAA 
GAATGAGGAGCTTCGGCAAAATGCCGACTAAGGCCTCCTTAGGTTTTGCC 
CCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCCGAAGTTCCTT 
TCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATT 
GGTCAATCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGG 
GCGGCTCTCAAAAGTTTTCAGACACAAATTAGGTTCGAGGGAGGAAACGG 
AGAGGAAAGGGAAAACTTGAGACGGAGGCGGGACTAAGGAAACGGCAGCT 
TGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTGAACGTTCCTTCCTC 
TTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGCA 
GAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCG 
GCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGT 
3.2. Bioinformatic analysis of the promoter region 
The search for TATA box and CAAT box within 4292 bp region revealed the 
presence of several TATA box and a CAAT box located far from the transcription 
start site. The location of these motifs on the region is given in Appendix B. The 
1000 bp selected promoter region is also searched for the presence of TATA box and 
CAAT box, it is seen that the predicted promoter site of KATNB1 gene does not 
contain any of them. Furthermore, the analysis for CG boxes showed that this 
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promoter region contains several CG boxes that are shown in red sequences in the 
table 3.2. The CpG island analysis revealed the presence of 1 CpG island, 332 
nucleotide in length positioned in the 611-942 bp of the 1000 bp promoter region. 
This CpG island is the only one island that is found within the 4292 bp region. The 
location of the CpG island is illustrated in the graph given in figure 3.1.  
Table 3.2 : CG box analysis of KATNB1 promoter 
TCATCTGTAAATGGGAACAGGAATTCCTACCTCTTATGGTTGTACTGGGC 
GTTATGTGAGCCCAAGGAGCCCTGACCTGCGGTGAGAGGCTGGAGGCCGA 
AGGGCAAGGTTCGAGGGGCTCTGGGTGCCTGGGACAACCTCTGGGCAACA 
GGGAGAGGCGGCTGCGGGGCCAAGTCCCTCCTAAGCGGCCACGCGAGAGG 
CCCTGAGTCGAGAAGGGTTACGGCGCTTCCCAGAGCCCACCCCGCCCAAC 
GTGTCACAAATAAAGCTGGCCTTTCTCCGATTCCCTGATTGCAGCCATTC 
AGGGAGCAGCCCCTTGCCCACGCATCCATTAGTCGAGGCGGTGGCTGCGT 
GTGCAGTGCTACAGGGTTCAGCGCCTGCCTCGGCTCCGGAATCAGGCTGT 
TTCCTTCTAGACCTCCCATGGGGGATTCAAGCCGGCGTCCGGGTCAAAGA 
ACAGGGACAAAGTCCTCCTGCCACGGGGGACCATCTGCAGGCAAAGTGAA 
GAATGAGGAGCTTCGGCAAAATGCCGACTAAGGCCTCCTTAGGTTTTGCC 
CCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCCGAAGTTCCTT 
TCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATT 
GGTCAATCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGG 
GCGGCTCTCAAAAGTTTTCAGACACAAATTAGGTTCGAGGGAGGAAACGG 
AGAGGAAAGGGAAAACTTGAGACGGAGGCGGGACTAAGGAAACGGCAGCT 
TGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTGAACGTTCCTTCCTC 
TTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGCA 
GAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCG 
GCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGT 
                 
Figure 3.1 : CpG island analysis of KATNB1 promoter. 
3.3. Deletion constructs determination 
Computer prediction analysis of putative binding sites for different transcriptional 
elements was accomplished via TRANSFAC® 7.0 Public 2005 program (Matys et al., 
2006). The database search predicted the presence of some transcription factors 
including Elk-1 with accession number (AC) T00250, Sp1 with AC T00759 and 
PEA3 with AC T00685. Sp1 with GCCCCGCCCC/GGGCGGG consensus sequence 
is represented in red, Elk-1 with GGAAG consensus sequence is represented in green 
and the PEA3 with AGGAAA consensus sequence is represented in blue in the 
alignment given in the table 3.3. 
 65
Table 3.3: Putative transcription factor binding site in 1000 base pair KATNB1 promoter 
TCATCTGTAAATGGGAACAGGAATTCCTACCTCTTATGGTTGTACTGGGC 
GTTATGTGAGCCCAAGGAGCCCTGACCTGCGGTGAGAGGCTGGAGGCCGA 
AGGGCAAGGTTCGAGGGGCTCTGGGTGCCTGGGACAACCTCTGGGCAACA 
GGGAGAGGCGGCTGCGGGGCCAAGTCCCTCCTAAGCGGCCACGCGAGAGG 
CCCTGAGTCGAGAAGGGTTACGGCGCTTCCCAGAGCCCACCCCGCCCAAC 
GTGTCACAAATAAAGCTGGCCTTTCTCCGATTCCCTGATTGCAGCCATTC 
AGGGAGCAGCCCCTTGCCCACGCATCCATTAGTCGAGGCGGTGGCTGCGT 
GTGCAGTGCTACAGGGTTCAGCGCCTGCCTCGGCTCCGGAATCAGGCTGT 
TTCCTTCTAGACCTCCCATGGGGGATTCAAGCCGGCGTCCGGGTCAAAGA 
ACAGGGACAAAGTCCTCCTGCCACGGGGGACCATCTGCAGGCAAAGTGAA 
GAATGAGGAGCTTCGGCAAAATGCCGACTAAGGCCTCCTTAGGTTTTGCC 
CCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCCGAAGTTCCTT 
TCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATT 
GGTCAATCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGG 
GCGGCTCTCAAAAGTTTTCAGACACAAATTAGGTTCGAGGGAGGAAACGG 
AGAGGAAAGGGAAAACTTGAGACGGAGGCGGGACTAAGGAAACGGCAGCT 
TGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTGAACGTTCCTTCCTC 
TTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGCA 
GAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCG 
GCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGT 
Deletion constructs were generated according to the search results by reasonably 
separating the transcription factor binding sites in a meaningful way. Deletion 
constructs sequence data are given in the table 3.4. 
Table 3.4: Deletion constructs data 
Names Sequences 
 
 
 
F2 (518bp) 
ATCTGCAGGCAAAGTGAAGAATGAGGAGCTTCGGCAAAATGCCGACTAAGGCCT 
CCTTAGGTTTTGCCCCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCC 
GAAGTTCCTTTCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACG 
CTGATTGGTCAATCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGA 
GGGCGGCTCTCAAAAGTTTTCAGACACAAATTAGGTTCGAGGGAGGAAACGGAG 
AGGAAAGGGAAAACTTGAGACGGAGGCGGGACTAAGGAAACGGCAGCTTGCATT 
GGTTTATTAGAGGCCAAGGGGCGGCTCTTGAACGTTCCTTCCTCTTGATTAGTC 
CTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGCAGAAGCGCCTGCTTC 
CATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGCAGCTGATTGGTGCGGG 
AGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGT 
 
F3 (279bp) 
ACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAA ACTTGAGACG 
GAGGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGC 
GGCTCTTGAACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGG 
TACTGAGGAAAAGCGGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAG 
GCGGAGCACCCGCGGCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTG 
AGCCGGAGGT 
 
F4 (226bp) 
GAGGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGC 
GGCTCTTGAACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGG 
TACTGAGGAAAAGCGGCAGAAGCGCCTGCTTCCATTG GTCAGTCCTGGCAGGA 
GGCGGAGCACCCGCGGCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCT 
GAGCCGGAGGT 
F5 (160bp) TTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAA 
GCGGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCG 
CGGCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGT 
F6 Long (23bp) GGGCGGGGCTCTGAGCCGGAGGT 
F7 Short (15bp) CTCTGAGCCGGAGGT 
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3.4. Amplification of KATNB1 constructs 
For pGL3-Basic deletion constructs construction, the promoter of 1000 bp (F1) was 
amplified with PCR. The resultant PCR products were run on agarose gel and the 
expected DNA fragment of 1000 bp was detected. PCR fragment is shown in figure 
3.2 compared to Fermentas Mass Ruler Mix DNA Marker (SM0403). 
 
Figure 3.2 : PCR amplified 1000 bp promoter DNA fragment. 
Amplified PCR product was designed to be inserted into Promega’s pGL3-Basic 
vector. Therefore, the PCR product and vector were double digested with 
Fermentas’s FastDigest Hind III and KpnI restriction enzymes. After purification 
step ligation was performed with Roche T4 DNA ligase. Subsequently, ligation 
mixture was transformed into CaCl2 treated E. coli DH5α competent cells. After the 
colonies emerged, in order to verify if the colonies contain the plasmid of interest, 
colony PCR was executed using pGL3-Basic sequencing primers. Seven colonies 
were analyzed by colony PCR, and the resultant amplicons were run on agarose gel. 
The expected DNA fragment of 1000 bp was detected in six colonies. PCR 
fragments are shown in figure 3.3 compared to Fermentas Mass Ruler Mix DNA 
Marker (SM0403). 
 
Figure 3.3 : Colony PCR amplified 1000 bp promoter DNA fragment. 
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Plasmid DNA was isolated from colony PCR positive colonies with QIAGEN’s 
Qiaprep Spin Miniprep Plasmid Isolation Kit.  
For the construction of other deletion constructs, pGL3-Basic-1000 bp promoter (F1) 
containing purified plasmid was used as template for PCR reactions. The resultant 
PCR products were run on agarose gel and the expected DNA fragments of 518 bp 
(F2), 279 bp (F3), 226 bp (F4) and 160 bp (F5) were detected. PCR fragments are 
shown in figure 3.4 compared to Fermentas Mass Ruler Mix DNA Marker (SM0403). 
                                      
Figure 3.4 : PCR amplified F2, F3, F4, F5 DNA fragments. 
Amplified PCR products were inserted into Promega’s pGL3-Basic vector the same 
way as for the 1000 bp promoter. After the colonies emerged following 
transformation, in order to verify if the colonies contain the plasmid of interest, 
colony PCR was executed with pGL3 sequencing primers. Three colonies were 
analyzed by colony PCR for each construct, and the resultant amplicons were run on 
agarose gel. The expected DNA fragment of 518 bp (F2), 279 bp (F3), 226 bp (F4) 
and 160 bp (F5) were detected. PCR fragments are shown in figure 3.5 compared to 
Fermentas Mass Ruler Mix DNA Marker (SM0403). 
 
Figure 3.5 : Colony PCR amplified F2, F3, F4, F5 DNA fragments. 
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Plasmid DNA’s were isolated from colony PCR positive colonies with QIAGEN’s 
Qiaprep Spin Miniprep Plasmid Isolation Kit.  
3.5. Sequence alignment analysis of the constructed plasmids 
Sequence analyses of the constructed plasmids were needed to be performed in order 
to verify the authenticity of the inserts. Even a single base mutation in the promoter 
region can lead to dramatic decrease of the promoter activity if it takes place in a 
transcription factor binding site, and that could lead to misinterpretation of the data. 
Analysis of sequence results was performed via EBI Clustalw sequence analysis tool. 
It is found that none of the constructed plasmid possesses any mutations. Analysis 
results are given in Appendix A. After confirming that none of the constructs possess 
any mutations, each construct was transformed with E.coli dam-/dcm- GM2163 
strain in order to prevent any methylation that can interfere the transcription factor 
binding, and after the colonies emerged the insert containing plasmids was 
reproduced in large scale and purified with QIAGEN, EndoFree® Plasmid Maxi kit. 
3.6. Luminometrical Measurements Data of Promoter Deletion Constructs 
SH-SY5Y neuroblastoma cells were transfected with each construct on the same day 
and each transfection was performed as triplicates. Although data are assayed in 
triplicate, it is not considered n=3 for drawing scientific conclusions, for that reason 
to have a meaningful data for each construct, at least three independent experiments 
were performed on separate days with independent samples. Recorded light units of 
independent experiments are given in the following tables. 
Table 3.5: Measured light units of experiment n=1 
n=1 Light  
Units 
F1 F2 F3 F4 F5 F6 F7 pGL3-
Basic 
1 Firefly 22,84 496 370,8 194,4 131,1 6,239 24,52 3,605 
Renilla 16,65 24,06 25,26 14,52 41,28 23,67 14,04 11,52 
2 Firefly 26,67 443,3 286,9 257,5 124,6 8,272 28,02 4,014 
Renilla 20,65 22,89 22,01 25,58 35,55 21,04 14,71 10,90 
3 Firefly 26,52 410,2 325,1 221,3 123 9,45 26,84 0,022 
Renilla 18,7 23,32 21,35 25,14 32,3 27,96 16,26 14,33 
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Table 3.6: Measured light units of experiment n=2 
n=
2 
Light 
Units 
F1 F2 F3 F4 F5 F6 F7 pGL3-
Basic 
1 Firefly 2,141 137,9 61,72 11,4 11,74 0,1124 0,3179 0,4201 
Renilla 4,103 14,58 3,133 3,133 3,688 0,5655 0,3574 1,361 
2 Firefly 3,752 120,8 37,79 26,06 3,276 0,6319 0,885 1,5 
Renilla 6,321 15,28 4,695 4,695 0,9914 2,55 1,025 5,505 
3 Firefly 3,691 213,9 49,13 46 0,9217 1,373 0,7318 2,146 
Renilla 3,83 28,56 12,98 12,98 0,7699 4,92 0,7861 7,333 
Table 3.7: Measured light units of experiment n=3 
n=3 Light 
Units 
F1 F2 F3 F4 F5 F6 F7 pGL3-
Basic 
1 Firefly 2,813 119,9 165,2 76,05 54,5 4,087 20,69 11,82 
Renilla 17,97 17,43 24,33 21,11 24,5 14,63 11,28 18,17 
2 Firefly 3,285 162,7 213,6 83,89 55,27 6,354 19,45 10,09 
Renilla 17,34 21,21 30,67 23,01 24,62 17,6 11,99 17,46 
3 Firefly 2,939 166,2 154,1 81,21 79,12 4,9 21,65 11,71 
Renilla 16,01 23,56 27,12 23,25 33,52 18,1 11,5 15,11 
The following equation is used to determine the normalized fold change in activity 
between test groups, considered as fold of induction in respect to the activity of the 
empty vector pGL3-Basic. The calculated fold activity and graphics representing the 
obtained data are given in the tables and figures below, 
                              Average (Firefly/Renilla) from Sample X 
∆ Fold Activity =                                                                                                    (3.1)                     
                              Average (Firefly/Renilla) from pGL3-Basic 
Table 3.8: Calculated ∆ Fold Activity of experiment n=1 
n=1 Ratio F1 F2 F3 F4 F5 F6 F7 pGL3-
Basic 
1 F/R 1,371 20,615 14,679 13,388 3,175 1,746 1,746 0.312 
2 F/R 1,291 19,366 13,034 10,066 3,504 1,904 1,944 0.368 
3 F/R 1,418 17,59 15,227 8,802 3,808 1,650 1,650 - 
Average F/R 1.36 19,19 14,313 10,752 10,487 1,766 1,78 0,34 
∆ Fold Activity 4,0 56,44 42,097 31,623 30,844 5,194 5,23 1 
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Figure 3.6: Graphic representing the calculated fold activity of experiment n=1. 
Table 3.9: Calculated ∆ Fold Activity of experiment n=2 
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Figure 3.7: Graphic representing the calculated fold activity of experiment n=2. 
Table 3.10: Calculated ∆ Fold Activity of experiment n=3 
n=2 Ratio F1 F2 F3 F4 F5 F6 F7 pGL3-
Basic 
1 F/R 0,521 9,4581 6,6508 3,6386 3,1832 0,1987 0,889 0.308 
2 F/R 0,5935 7,9057 11,101 5,5505 3,3044 0,252 0,863 0.272 
3 F/R 0,9637 7,4894 9,2768 3,5439 1,1971 0,2790 0,9309 0.292 
Average F/R 0.6930 8,2844 9,0097 4,2443 2,5616 0,2435 0,8944 0,2912 
∆ Fold Activity 2,3793 28,442 30,933 14,572 8,7947 0,8361 3,0709 1 
n=3 Ratio F1 F2 F3 F4 F5 F6 F7 pGL3- 
Basic 
1 F/R 0,157 6,879 6,79 3,603 2,224 0,279 1,834 0,651 
2 F/R 0,190 7,671 6,964 3,646 2,245 0,361 1,622 0,578 
3 F/R 0,184 7,054 5,682 3,493 2,360 0,271 1,883 0,775 
Average F/R 0,177 7,201 6,479 3,58 2,277 0,3037 1,78 0,668 
∆ Fold Activity 0,265 10,78 9,699 5,359 3,409 0,4555 2,665 1 
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Figure 3.8: Graphic representing the calculated fold activities of experiment n=3. 
The normalized fold changes in activity from each experiment are then averaged 
together, and the standard deviation is calculated in MS Excel. The data is analysed 
to elucidate whether there is a statistically meaningful difference between the 
constructs that are following each other via two- tailed unpaired t-test in GraphPad 
InStat 3 statistic program. Asterisk symbol (*) shown on the average table represents 
that the p-value is less than 0,005 which is considered a statistically meaningful 
difference, wheras not significant (NS) symbol represents that the p-value is greater 
than 0,005 which is not considered a statistically meaningful difference. The data is 
given in the table 3.11. 
Table 3.11: Average of calculated F/R of all experiments and standard deviation 
 
Experiments 
F/R 
F1 F2 F3 F4 F5 F6 F7 pGL3 
Basic 
n=1 1,36 19,19 14,313 10,75 10,487 1,766 1,78 0,34 
n=2 0,693 8,284 9,0097 4,244 2,5616 0,2435 0,89 0,291 
n=3 0,177 7,201 6,479 3,58 2,277 0,3037 1,78 0,668 
Average  F/R 0,743 11,55 9,9339 6,192 5,1085 0,7710 1,48 0,433 
Average F/R 
Standard Deviation 0,593 6,631 3,9979 3,962 4,6600 0,8621 0,51 0,205 
∆ Average F/R   
Fold Activity 
1,716
7 
26,69
3 
22,942
0 14,3 11,798 1,7807 3,42 1 
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Figure 3.9: Graphic representing the calculated fold activities of average of the experiments 
                            and standard deviation. 
3.7. Evaluation of the luminometrical measurement data of promoter deletion 
constructs 
For the evaluation of the luminometrical measurements data, PROMO bioinformatics 
tool was used (Messeguer et al., 2002, Farre et al., 2003). The search for KATNB1 
promoter was done by selecting factor’s species as Homo sapiens and site species as 
Homo sapiens and by restriction the search maximum matrix dissimilarity rate as 5% 
and the search revealed the presence of 32 transcription factors. Matrix dissimilarity 
rate stands for the similarity between the given sequence in the promoter and the 
consensus sequence of the transcription factors. The names and the location of the 
factors on the KATNB1 1000 bp promoter was given in the following figure 3.10 
and figure 3.11, respectively. The research results for Sp1 binding sites shown with 
number 10 and Elk-1 shown in number 25 can be seen in figure 3.12. 
 
Figure 3.10: Homo sapiens factors predicted within a dissimilarity margin less or equal than 5 %. 
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Figure 3.11: Predicted Homo sapiens factors location on the promoter. 
 
Figure 3.12: Research results for Sp1 an Elk-1 transcription factor binding sites in                          
KATNB1 promoter with matrix dissimilarity rate as 5%. 
Another search by selecting factor’s species as Eutheria, and site species as Eutheria, 
and by restriction the search maximum matrix dissimilarity rate as 5% revealed the 
presence of 124 transcription factors. The names and the location of the factors on 
the KATNB1 1000 bp promoter was given in the following table 3.13 and figure 
3.14 respectively. The research results for PEA3 binding sites shown with number 33 
can be seen in figure 3.15. 
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Figure 3.13: Eutheria factors predicted within a dissimilarity margin less or equal than 5 %. 
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Figure 3.14: Predicted eutheria factors location on the promoter. 
 
Figure 3.15: Research results for PEA3 transcription factor binding sites                                                                
in KATNB1 promoter with matrix dissimilarity rate as 5%. 
A summary of these computational analysis results is illustrated in the figure 3.16.  
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Figure 3.16: Illustration of the KATNB1 promoter binding sites                                                                          
by Elk-1, PEA3 and Sp1 transcription factors. 
 
 
 
 77
3.8. Luminometrical Measurements Data of Forced Experiments 
SH-SY5Y neuroblastoma cells were transfected with only F2 deletion construct and 
the same construct were transfected together with Elk-1, Elk-1-VP16 or PEA3 
transcription factors expressing constructs. This setup will give the opportunity to 
evaluate the effects of transcription factors on the promoter. Again the same way as 
the deletion constructs transfection, the construct was transfected on the same day 
and each transfection was performed as triplicate and the experiments are replicated 
at least two times on separate days with independent samples to have a meaningful 
data. Recorded light units of independent experiments are given in tables below,  
▪ Elk-1 forced experiments, 
Table 3.12: Measured light units of Elk-1 forced experiment n=1 
n=1 Light  
Units 
F2 pGL3-
Basic 
F2 
Elk-1 
pGL3Basic 
Elk-1 
1 Firefly 78,58 3,519 27,48 1,827 
Renilla 10,43 7,1191 55,32 38,92 
2 Firefly 85,47 4,238 25,51 1,818 
Renilla 12,23 10,114 58,73 54,54 
3 Firefly 60,11 8,17 21,62 2,992 
Renilla 7,513 21,688 47,22 18,74 
Table 3.13: Measured light units of Elk-1 forced experiment n=2 
n=2 Light  
Units 
F2 pGL3-
Basic 
F2 
Elk-1 
pGL3Basic 
Elk-1 
1 Firefly 156,5 3,511 20,08 0,9267 
Renilla 10,39 8,438 64,09 30,24 
2 Firefly 159,1 4,238 22,83 1,212 
Renilla 13,76 9,613 62,06 37,61 
3 Firefly 0,0052 8,178 16,42 0,8381 
Renilla 0,0083 20,23 57,07 21,42 
Table 3.14: Measured light units of Elk-1 forced experiment n=3 
n=3 Light  
Units 
F2 pGL3-
Basic 
F2 
Elk-1 
pGL3Basic 
Elk-1 
1 Firefly 15,823 11,82 42,81 3,51 
Renilla 2,3 18,17 54,03 39,45 
2 Firefly 16,344 10,09 21,93 1,346 
Renilla 2,13 17,46 28,42 20,707 
3 Firefly 13,102 11,71 31,13 2,57 
Renilla 1,857 15,11 45,43 32,125 
The equation used for the analysis of the deletion constructs data to determine the 
normalized fold change in activity between test groups was used. The calculated fold 
activity and graphics representing the obtained data are given in the tables and 
following figures. 
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Table 3.15: Calculated ∆ Fold Activity of Elk-1 forced experiment n=1 
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Figure 3.17: Graphic representing the calculated fold activities of Elk-1 forced experiment n=1. 
Table 3.16: Calculated ∆ Fold Activity of Elk-1 forced experiment n=2 
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Figure 3.18: Graphic representing the calculated fold activities of Elk-1 forced experiment n=2. 
n=1 Ratio F2 pGL3-
Basic 
F2 
Elk-1 
pGL3Basic 
Elk-1 
1 F/R 7,5340 0,4943 0,4967 0,0469 
2 F/R 6,9885 0,419 0,4343 0,0333 
3 F/R 8,0007 0,3767 0,4578 0,1596 
Average F/R 7,5078 0,430 0,4629 0,0799 
∆ Fold Activity 17,459 1 5,789 1 
n=2 Ratio F2 pGL3-
Basic 
F2 
Elk-1 
pGL3-Basic 
Elk-1 
1 F/R 15,0625 0,4160 0,31330 0,030645 
2 F/R 11,5625 0,4408 0,36787 0,032225 
3 F/R - 0,4042 0,28771 0,039127 
Average F/R 13,3125 0,4204 0,32296 0,03399 
∆ Fold Activity 31,6661 1 9,49923 1 
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Table 3.17: Calculated ∆ Fold Activity of Elk-1 forced experiment n=3 
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Figure 3.19: Graphic representing the calculated fold activities of Elk-1 forced experiment n=3. 
The normalized fold changes in activity from each experiment are then averaged 
together and the standard deviation is calculated in MS Excel. The data is analysed to 
elucidate whether there is a statistically meaningful difference between the unforced 
and the forced experiments via two-tailed unpaired t-test in GraphPad InStat 3 
statistic program. Asterisk symbol (*) shown on the average table represents that the 
p-value is less than 0,005 which is considered a statistically meaningful difference. 
The data is given in the table 3.18. 
Table 3.18: Average of calculated F/R of Elk-1 forced experiments and standard deviation 
 
 
 
 
 
 
 
 
n=3 Ratio F2 pGL3-
Basic 
F2 
Elk-1 
pGL3-Basic 
Elk-1 
1 F/R 6,879 0,651 0,792 0,089 
2 F/R 7,671 0,578 0,77 0,065 
3 F/R 7,054 0,775 0,685 0,08 
Average F/R 7,2010 0,668 0,75 0,078 
∆ Fold Activity 10,77 1 9,61 1 
Experiments 
F/R 
F2 pGL3- 
Basic 
F2 
Elk-1 
pGL3-
Basic 
Elk-1 
n=1 7,5078 0,430 0,4629 0,0799 
n=2 13,3125 0,4204 0,32296 0,0339 
n=3 7,2010 0,668 0,75 0,078 
Average  F/R 9,34045 0,50613 0,51198 0,0639 
Average F/R 
Standard Deviation 3,44333 0,14026 0,217693 0,026 
∆ Average F/R    
 Fold Activity 18,4545 1 8,008 1 
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Figure 3.20 : Graphic representing the calculated fold activities of average of Elk-1 forced 
                                the experiments  and standard deviation. 
▪ Elk-1-VP16 forced experiments, 
Table 3.19: Measured light units of Elk-1-VP16 forced experiment n=1 
n=1 Light  
Units 
F2 pGL3-
Basic 
F2 
Elk-1 
pGL3Basic 
Elk-1-VP16 
1 Firefly 78,58 3,519 190,6 5,331 
Renilla 10,43 7,1191 22,25 8,675 
2 Firefly 85,47 4,238 245,1 6,666 
Renilla 12,23 10,114 25,59 9,699 
3 Firefly 60,11 8,17 257,3 4,849 
Renilla 7,513 21,688 24,12 9,28 
Table 3.20: Measured light units of Elk-1-VP16 forced experiment n=2 
n=2 Light  
Units 
F2 pGL3-
Basic 
F2 
Elk-1-
VP16 
pGL3Basic 
Elk-1-VP16 
1 Firefly 59,75 5,475 104,1 5,331 
Renilla 6,496 6,87 15,73 8,675 
2 Firefly 53,44 4,315 96,22 6,666 
Renilla 8,663 7,217 15,92 9,699 
3 Firefly 50,06 4,646 93,43 4,849 
Renilla 6,677 8,211 17,08 9,28 
 
The equation used for the analysis of the deletion constructs data to determine the 
normalized fold change in activity between test groups was used. The calculated fold 
activity and graphics representing the obtained data are given in the following tables 
and figures. 
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Table 3.21: Calculated ∆ Fold Activity of Elk-1-VP16 forced experiment n=1 
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Figure 3.21: Graphic representing the calculated fold activities of Elk-1-VP16 forced  
                                   experiment n=1. 
Table 3.22: Calculated ∆ Fold Activity of Elk-1-VP16 forced experiment n=2 
 
 
 
 
 
 
n=1 Ratio F2 pGL3-
Basic 
F2 
Elk-1 
VP16 
pGL3-Basic 
Elk-1- 
VP16 
1 F/R 7,534036 0,4943 8,5662 0,61452 
2 F/R 6,988553 0,419 9,577 0,68729 
3 F/R 8,000799 0,3767 10,66 0,52252 
Average F/R 7,507796 0,43 9,6039 0,6081 
∆ Fold 
Activity 17,45999 1 15,793 1 
n=2 Ratio F2 pGL3-
Basic 
F2 
Elk-1 
VP16 
pGL3Basic 
Elk-1- 
VP16 
1 F/R 9,19797 0,79694 6,61793 0,61452 
2 F/R 6,16876 0,59789 6,04397 0,68729 
3 F/R 7,49738 0,56583 5,47014 0,52252 
Average F/R 7,62137 0,65355 6,04401 0,6081 
∆ Fold Activity 11,6614 1 9,93899 1 
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Figure 3.22: Graphic representing the calculated fold activities of Elk-1-VP16 forced experiment n=2. 
The normalized fold changes in activity from each experiment are then averaged 
together, and the standard deviation is calculated in MS Excel. Data is analysed to 
elucidate whether there is a statistically meaningful difference between the unforced 
and the forced experiments via two-tailed unpaired t-test in GraphPad InStat 3 
statistic program. Asterisk symbol (*) shown on the average table represents that the 
p-value is less than 0,05 which is considered a statistically meaningful difference. 
The data is given in the table 3.23. 
Table 3.23: Average of calculated F/R of Elk-1-VP16 forced experiments and standard deviation 
 
 
 
 
 
Experiments 
F/R 
F2 pGL3- 
Basic 
F2 
Elk-1 
pGL3-
Basic 
Elk-1 
n=1 7,50779 0,43 9,6039 0,6081 
n=2 7,62137 0,65355 6,04401 0,6081 
Average  F/R 7,56458 0,54177 7,823955 0,6081 
Average F/R 
Standard Deviation 0,0803 0,1580 2,51722 0 
∆ Average F/R    
 Fold Activity 13,9625 1 12,86611 1 
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Figure 3.23: Graphic representing the calculated fold activities of average of                                                               
                Elk-1-VP16 forced the experiments and standard deviation. 
▪ PEA3 forced experiments, 
Table 3.24: Measured light units of PEA3 forced experiment n=1 
n=1 
 
Light  
Units 
F2 pGL3-
Basic 
F2 
PEA3 
pGL3-Basic 
PEA3 
1 Firefly 242,6 12,42 148,9 - 
Renilla 27,71 21,26 12,95 - 
2 Firefly 266,2 13,02 175,7 7,112 
Renilla 32,02 21,11 13,27 10,26 
3 Firefly 200,3 18,31 193,7 8,904 
Renilla 33,6 21,62 14,36 11,14 
Table 3.25: Measured light units of PEA3 forced experiment n=2 
n=2 
 
Light  
Units 
F2 pGL3-
Basic 
F2 
PEA3 
pGL3-Basic 
PEA3 
1 Firefly 156,5 3,511 106,8 4,868 
Renilla 10,39 8,438 16,77 16,86 
2 Firefly 159,1 4,238 115,6 4,992 
Renilla 13,76 9,613 21,7 33,37 
3 Firefly 0,0052 8,178 96,35 5,311 
Renilla 0,0083 20,23 35,57 24,75 
Table 3.26: Measured light units of PEA3 forced experiment n=3 
n=3 
 
Light  
Units 
F2 pGL3-
Basic 
F2 
PEA3 
pGL3-Basic 
PEA3 
1 Firefly 201,3 11,82 193,2 8,56 
Renilla 29,6 18,17 15,44 11,428 
2 Firefly 256,78 10,09 191,6 9,345 
Renilla 34,532 17,46 10,1 11,341 
3 Firefly 218,69 11,71 138,6 7,35 
Renilla 29,628 15,11 11,18 11,05 
The equation used for the analysis of the deletion constructs data to determine the 
normalized fold change in activity between test groups was used. The calculated fold 
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activity and graphics representing the obtained data are given in the tables and 
figures below, 
Table 3.27: Calculated ∆ Fold Activity of PEA3 forced experiment n=1 
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Figure 3.24: Graphic representing the calculated fold activities of PEA3 forced experiment n=1. 
Table 3.28: Calculated ∆ Fold Activity of PEA3 forced experiment n=2 
 
 
 
 
 
 
 
 
 
 
 
 
n=1 Ratio F2 pGL3-
Basic 
F2 
PEA3 
pGL3-Basic 
PEA3 
1 F/R 8,75496 0,5842 11,4981 - 
2 F/R 8,31355 0,6167 13,2404 0,69318 
3 F/R 5,96131 0,8469 13,4889 0,79928 
Average F/R 7,67661 0,6826 12,7424 0,746 
∆ Fold 
Activity 11,246 
 
1 17,081 1 
n=2 Ratio F2 pGL3-
Basic 
F2 
PEA3 
pGL3-Basic 
PEA3 
1 F/R 15,0626 0,41609 6,36852 0,28873 
2 F/R 11,5625 0,44086 5,32719 0,1496 
3 F/R 0,6265 0,40425 2,70874 0,21459 
Average F/R 9,08385 0,4204 4,80148 0,21764 
∆ Fold 
Activity 21,607 
 
1 22,0615 1 
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Figure 3.25: Graphic representing the calculated fold activities of PEA3 forced experiment n=2. 
Table 3.29: Calculated ∆ Fold Activity of PEA3 forced experiment n=3 
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Figure 3.26: Graphic representing the calculated fold activities of PEA3 forced experiment n=3. 
The normalized fold changes in activity from each experiment are then averaged 
together, and the standard deviation is calculated in MS Excel. Data is analysed to 
elucidate whether there is a statistically meaningful difference between the unforced 
and the forced experiments via two-tailed unpaired t-test in GraphPad InStat 3 
statistic program. Not significant (NS) symbol shown on the average table represents 
n=3 Ratio F2 pGL3-
Basic 
F2 
PEA3 
pGL3-
Basic 
PEA3 
1 F/R 6,786 0,651 12,512 0,749 
2 F/R 7,436 0,578 18,97 0,824 
3 F/R 7,381 0,775 12,397 0,665 
Average F/R 7,20104 0,668 14,63 0,746 
∆ Fold 
Activity 10,78 
 
1 
 
19,611 
 
1 
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that the p-value is greater than 0,05 which is not considered a statistically meaningful 
difference. The data is given in the table 3.30. 
Table 3.30: Average of calculated F/R of PEA3 forced experiments and standard deviation 
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Figure 3.27: Graphic representing the calculated fold activities of average of PEA3 forced 
                               the experiments  and standard deviation. 
 
 
 
 
 
 
Experiments 
F/R 
F2 pGL3- 
Basic 
F2 
PEA3 
pGL3-Basic 
PEA3 
n=1 7,67661 0,6826 12,7424 0,746 
n=2 9,08385 0,4204 4,80148 0,2176 
n=3 7,20104 0,668 14,63 0,746 
Average  F/R 7,98717 0,59034 10,72463 0,5698 
Average F/R 
Standard Deviation 0,97907 0,14735 5,2157 0,305 
∆ Average F/R    
 Fold Activity 13,962 1 18,2059 1 
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4. DISCUSSION  
As outlined in the introduction katanin is a heterodimeric protein that severes 
microtubules by hydrolyzing ATP, consisting of 60 kDa and 80 kDa polypeptides. 60 
kDa subunit (p60) has the enzymatic activity to break microtubules, whereas 80 kDa 
subunit (p80) has a role in localization of the protein complex in the cell. Katanin has 
been shown to have roles for microtubule severing in mitotic cells including release 
of microtubules from centrosome, depolymerization of microtubule minus ends in 
the mitotic spindle. In addition to its roles in mitotic cells, katanin is also important 
for some specialized cell types such as neurons. It is thought that katanin provides a 
source of non-centrosomal microtubules that are transported into developing axons 
and dendrites for structural support. 
Despite the importance of this gene, its transcriptional regulation has not been 
studied, and its promoter has not yet been characterized. We therefore set out to 
identify the potential cis-regulatory elements including the promoter of the KATNB1 
gene coding for katanin p80 subunit. 
In order to understand the transcriptional regulation of human KATNB1 gene we 
have first determined the putative promoter region in the upstream of KATNB1 gene. 
Bioinformatic analysis revealed that putative KATNB1 gene promoter is located on 
chromosome 16 between CCDC135 and KATNB1 genes according to NCBI Map 
Viewer database. This 4292 bp region comprise the promoter region of KATNB1 
gene. The search for TATA box and CAAT box within 4292 bp region revealed the 
presence of several TATA box and a CAAT box, but those motifs can not be 
functional because they are located very far from the transcription start site since 
according to litterature data a functional TATA box must be located within 25 to 30 
bp upstream of the transcription start site. Furthermore, the analysis for CG boxes 
showed that promoter region contains several CG boxes and the CpG island analysis 
revealed the presence of 1 CpG island, 332 nucleotide in length positioned in the 
611-942 bp of the last 1000 bp promoter region. This CpG island is the only one 
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island that is found within the 4292 bp region. The presence of these motifs is 
important because it is known that the cytosine and guanine rich sequences in the 
promoter regions of genes are the candidate regions for transcription factor binding. 
The dinucleotide CG is underrepresented in vertebrate DNAs, and the presence of a 
CG-rich region, or CpG island, just upstream of the start site is a distinctly 
nonrandom distribution. For this reason, the presence of a CpG island in genomic 
DNA suggests that it may contain a transcription-initiation region (Lodish et al., 
2004). In this context, we thought that the promoter of KATNB1 gene might be 
regulated by trascription factor binding to those CG rich regions in the last 1000 bp 
of the putative promoter region. That is why we have selected the last 1000 bp 
promoter region for further deletion construct studies. Before creating the 5’ 
truncation of the promoter, computer prediction analysis for putative binding sites for 
different transcriptional elements was accomplished via TRANSFAC® 7.0 Public 
2005 program (Matys et al., 2006). The analysis predicted the presence of Elk-1, 
PEA3, Sp1 binding sites. In order to ascertain which transcription factors are 
involved in the transcriptional regulation, we designed the deletion constructs by 
separating the CG boxes and other putative factors. Meaning that, each construct 
lacks one or more CG box or transcription factor binding site between mentioned 
transcription factors than its shorter form.  
In order to evaluate which part of the promoter has a role in driving transcription, we 
cloned first the 1000 bp promoter from human genomic DNA isolated from whole 
blood. Cloning experiment was repeated until we would get the wild-type promoter 
sequence. We have come across with sequence analysis showing some point 
mutations. These mutations can either be polymorphism or can be misintegration of 
nucleotides by the Taq polymerase used in the PCR. The deletion constructs were 
then amplified from the wild type 1000 bp promoter. The deletion constructs are 
cloned into pGL3-Basic luciferase reporter vector. Those vectors are named as 
pGL3-Basic-F(1...6), F1 representing the longer 1000 bp construct and F6 the shorter 
one respectively. Since this vector lacks eukaryotic promoter and enhancer sequences, 
expression of luciferase activity in cells transfected with this plasmid depends on 
insertion and proper orientation of a functional promoter directionally upstream from 
luc+ providing us the data about which part of the promoter has a role in driving 
transcription.  
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The type of cells that will be used in the genetic reporter assay transfections, depends 
on the anticipated expression pattern of the genes whose regulatory sequences are to 
be studied. SH-SY5Y human neuroblastoma cell line was chosen to be transfected 
with pGL3-Bacis-F constructs due to its neuronal origin. 
We tried to optimize transfection of SH-SY5Y cells first with nucleoporation method. 
According to literature data, the expression of luciferase activity in cells transfected 
with the reporter plasmids was measured 48 hours post-transfection. When we 
measured the full length promoter F1 activity, although the luciferase assay system is 
highly sensitive and can report even a few femtograms of luciferase we could not 
detect any luminescence. But, later we found out that optimal analysis time usually is 
6-16 hours after nucleofection due to its ability to deliver substrates not only into the 
cytoplasm but also into the nucleus of the cell and thus reducing time to expression. 
When we measured the full length promoter F1 activity, 16 hours post-transcription 
finally, we have detected luciferase activity. Yet, this nucleofection method requires 
a large number of cells (1x106 cells/transfection) and excessive amount of DNA 
(10µg/transfection) and this was not very feasible thinking that we were going to 
repeat each transfection in triplicate for at least two times to have a meaningful data 
and also would be very hard to handle so many plates, and would consume a lot of 
culture media and DNA. Hence, we switched our transfection method to cationic 
lipid mediated transfection. In that method, opposite to nucleofection, a minimum 
number of cells (0,05x106/ transfection) and DNA (1µg/transfection) were needed 
and it was easy to handle the cells in 24-well cell culture plates with minimal culture 
media. In case we measured the luciferase activity 48 hour post-transfection. During 
the transfection, along with the pGL3-Basic-F constructs, pRL-TK vector containing 
a cDNA encoding renilla luciferase is transfected to cells intended for use as an 
internal control. The amount of internal control vector needed depends on the control 
promoter and the cell line. According to manufacturer instruction, we used a ratio of 
10:1 test vector:control vector (Schagat et al., 2007). In this study, dual reporters 
assay system is chosen because dual reporters are commonly used to improve 
experimental accuracy. Our experimental reporter, pGL3-Basic-F is correlated with 
the effect of specific experimental conditions, while the activity of our co-transfected 
control reporter, pRL-TK provides an internal control that serves as the baseline 
response. Normalizing the activity of the pGL3-Basic-F to the activity of the pRL-
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TK minimizes experimental variability caused by differences in cell viability, 
transfection efficiency, differences in pipetting volumes, cell lysis efficiency and 
assay efficiency.  
The producer of the pGL3-Basic vectors claimed that they removed cryptic 
regulatory sequences from the luc+ gene without changing the encoded amino acids 
and from the vector backbone. Removal process of these cryptic regulatory sequence 
like a transcription factor binding site and/or a promoter module, sequences 
resembling splice sites, poly(A) addition sequences, Kozak sequence (translation 
start for mammalian cells) and E. coli promoters or E. coli ribosome binding sites 
said to lead to a greatly reduced number of cryptic regulatory sequences. But the 
manufacturers also announced that their pGL3-Basic vectors have recently been 
improved by further cleaning the entire pGL3-Basic vector backbone, removing 
cryptic regulatory sequences wherever possible, while maintaining its functionality 
to create unique vector backbone of the pGL4 Luciferase Reporter Vectors (Promega 
Protocols and Application Guide 8, 2008). The presence of cryptic regulatory 
sequences in the reporter vector may adversely effect transcription, resulting in 
anomalous expression of the reporter and to misinterpretation of the data. Taking this 
into the account, in order to minimize the effects of the possible cryptic regulatory 
elements in the reporter vector, while interpreting the luciferase measurement data 
Firefly/Renilla normalized activity is further normalized as fold of induction in 
respect to the activity of the empty vector pGL3-Basic. Hence, any possible cryptic 
promoter element within the pGL3-Basic vector that can bind on trancriptrion factors 
from SH-SY5Y cells is eliminated from the data of the promoter region. The results 
of luciferase reporter assay for the KATNB1 gene promoter deletion constructs in 
SH-SY5Y neuroblastoma cells is given in the following graphic. 
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Figure 4.1: Luciferase reporter assay results for the KATNB1 gene promoter                                            
in SH-SY5Y neuroblastoma cells. 
For the evaluation of the luminometrical measurements data, PROMO bioinformatics 
tool was used (Messeguer et al., 2002, Farre et al., 2003). Computer prediction 
analysis was performed many times with different selection of the program. For 
example, program suggested binding sites for the presence of 14 transcription factors 
when selecting factor’s species as Homo sapiens and site species as Homo sapiens 
and by restriction the search maximum matrix dissimilarity rate as 0%. When this 
dissimilarity rate was increased to 3% it detects 27 factors, when increased to 5%, 32 
transcription factors were detected. The importance for us was to see where our 
predicted factors, namely Sp1, Elk-1 and PEA3 binding sites will be revealed. We 
could not come across with Sp1 and Elk-1 binding site with 0% dissimilarity rate. 
When the dissimilarity rate was set to 3%, three putative Sp1 binding sites and one 
putative Elk-1 binding site appeared. When the rate was set to 5% the number of 
possible interaction sites were rised to 5 for Sp1 and did not change for Elk-1.  
Since we could not come across with the binding site for PEA3 we have changed the 
selection parameters of the program to factor’s species as eutheria and site species as 
eutheria. Program suggested binding sites for the presence of only one PEA3 
transcription factor binding site if chosen the search maximum matrix dissimilarity 
rate as 0%. This transcription factor was from mouse origin with accession number 
T00684. When the search maximum matrix dissimilarity rate was increased to 3%, 
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six binding sites appeared. Finally, with 5% dissimilarity rate, we have come across 
with seven PEA3 binding sites. Factors binding characteristics of each deletion 
constructs of the KATNB1 gene promoter are illustrated in figure 4.2. Underlined 
factors are the ones that differ the construct from the following one. 
 
Figure 4.2: Factors binding characteristics of each deletion constructs of the KATNB1 gene promoter. 
In the light statistical data of the luciferase reporter assay results for the KATNB1 
gene promoter in SH-SY5Y neuroblastoma cells and computational transcription 
factor binding studies, it can be speculated that the 482 bp portion of the longer 
construct F1 differing it from its shorter one F2 possesses some inhibitory binding 
sites for some transcriptional regulators causing its minimal relative luciferase unit 
(RLU). It is seen that 5’-truncations of F2 construct is leading to a decrease in the 
promoter activity showing that this part of the promoter is required for the core 
promoter activity and this 518 bp TATA-less promoter which is statistically different 
from construct F1 is sufficient for high levels of promoter activity. When the          
5’-239 bp were depleted in the F2 construct, it is seen that this deletion does not lead 
to a statistically different change in the promoter activity. Further 5’-truncation of F3 
construct also does not lead to a statistically meaningful decrease in the promoter 
activity. The 66 bp between the F4-F5 constructs possess one PEA3 and also one Sp1 
binding site, and a statistically meaningful decrease in the promoter activity is 
observed, meaning that PEA3 and/or Sp1 are acting on the promoter activity. The 
most dramatic statistically meaningful decrease in the promoter activity occurs when 
137 bp was truncated from 5’-end of the F5 construct. This region contains two 
PEA3, one Elk-1 and also one Sp1 site, and we know from executed computational 
analysis that this region of the promoter contains a CpG island and is found to be rich 
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for CG nucleotides. This dramatic increase in the promoter activity is concordant 
with our hypothesis saying that this part of the KATNB1 promoter might be 
regulated by transcription factor binding to those CG rich regions. This decrease can 
be due to the truncation of the Sp1 site, because it is known that Sp family 
transcription factors preferentially binds to CG boxes or maybe due to PEA3 binding 
site loss. We have designed the last two short construct in order to see if the 
truncation of the Sp1 binding site from F6 to F7 will lead to a decrease in the 
promoter activity. Surprisingly, the luminometrical studies results are showing that 
thre depletion of Sp1 binding site does not lead to a statistically different change in 
the promoter activity, meaning that the Sp1 transcription factor does not bind to this 
predicted region despite the fact that it contained an intact CG box. We could not 
further analyze the consequences of Sp1 transcription factor effects on the promoter 
due to absence of its coding vector.  
Regarding to the computational analysis of the promoter and with the light of the 
luciferase assays data, we further searched the Elk-1 and PEA3 transcription factors 
activity on KATNB1 promoter. We analyzed their activity with forced luciferase 
experiments by transfecting plasmids with human Elk-1 coding plasmids and mouse 
PEA3 coding plasmids along with the identified core promoter region, F2 construct.  
Since we did not have human PEA3 coding plasmid we used the mouse one, after all 
those transcription factors consensus sequences show a great homology.  
PEA3 transcription factors embryonic expression patterns and aberrant expression in 
metastatic tumors, suggest a role for PEA3 proteins in regulating cell motility during 
organogenesis/development and during tumor progression (Greenall et al., 2001). 
Due to its developmental pattern of expression it has been suggested that it may play 
a role in the development of the somites and in regionalization of the nervous system 
(Brown et al., 1998). Other roles of PEA3 group transcription factors are shown 
recently, they are found to be expressed in tissues undergoing branching 
morphogenesis and promote formation of duct-like structures by mammary epithelial 
cells in vitro (Chotteau-Lelièvre et al., 2003).  
Our protein of interest katanin p80 is widely expressed in the nervous system and in 
mitotic cells, taking part of severing microtubules with its partner p60 it is mainly 
responsible of generating free microtubules, participating the regulation of cell cycle 
progression, regulation of axonal growth, and branch formation. 
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Both proteins seem to have interacting action areas, while PEA3 is responsible of 
cell motility during organogenesis/development, tumor progression and expressed in 
tissues undergoing branching morphogenesis, katanin p80 also has a role in 
regulation of cell cycle progression, regulation of axonal growth, branch formation 
an also through its role in mitosis katanin seems to be related with mitogenic tumor 
cells. To that end, we were expecting that PEA3 factor will lead to an increase in the 
promoter activity. Forced expression of  PEA3 along with F2 construct in transfected 
SH-SY5Y human neuroblastoma cells did not result with a statistically meaningful 
change in the promoter activity.  
The situation is less clear with Elk-1 transcription factor. Since ETS domain proteins 
can function as either transcriptional activators or repressors (Sharrocks et.al., 1997), 
and also some family members including Elk-1 were shown to have both repressive 
and activating abilities (Sharrocks, 2001). Elk-1 is a direct target of the MAP kinase 
pathways, when phosphorylated by MAP kinases, its activation is triggered, and it 
has been shown that SUMO modification of its R motif will lead to its repression. 
There is a dynamic interplay between the activating MAPK pathway and SUMO 
pathway (Yang et al., 2003).  Elk-1 is important in neuronal systems in particular for 
processes such as fear conditioning, light stimulus, and glutamate induction. This 
protein is traditionally known as a mitogenic factor, mostly associated with 
proliferation thus the molecular mechanism underlying its effects on these learning 
and synaptic plasticity related events in post-mitotic neurons are not yet understood 
(Aksan-Kurnaz, 2009). It has been showed that Elk-1 protein biochemically 
interacted with microtubules in vitro. It was further demonstrated that upon serum 
induction, most of the phospho-Elk-1 translocates to the nucleus, which is 
independent of translation. This leads to the idea that Elk-1 is anchored to neuronal 
microtubules in resting or unstimulated cells. Upon stimulation, its phosphorylated 
form, phospho-Elk-1, relocalizes to the nucleus in neurons where it is proposed to 
regulate neuronal target genes (Demir et al., 2008). It was also demonstrated that 
Elk-1 represses pro-apoptotic genes such as egr-1 in SH-SY5Y neuroblastomas in a 
SUMO dependent manner (Demir and Aksan Kurnaz, 2008). We were curious as to 
whether Elk-1 would activate or repress KATNB1 expression. Forced expression 
analysis of  wild type Elk-1 under the control of activating MAPK pathway and 
repressing SUMO pathway in transfected SH-SY5Y human neuroblastoma cells 
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along with F2 construct resulted in a statistically meaningful decrease of the 
promoter activity. In the light of these results, we sought to understand whether its 
repression domain would be directly involved in the repression and whether Elk-1 
would be switched from a repressor to an activator. To test that hypothesis, Elk-1-
VP16 a constitutively active Elk-1 construct was transfected along with F2 construct. 
If the repression was due to the effect of SUMO modification, this transfection 
would result in an increase of the promoter activity. Strikingly, we have come across 
with similar results. Since the effect on the promoter activity of these two constructs 
is statistically different, a comparaison between wild type Elk-1 and Elk-1-VP16 
transfection results in an increased activity in case of Elk-1-VP16 construct but still 
much less from the unforced activity of the F2 construct, meaning that the repression 
occurs in SUMO dependent way, in addition to some other modifications of Elk-1. 
The comparison between Elk-1 and Elk-1-VP16 on the promoter activity can be seen 
the figure 4.3. Asterisk symbol (*) shown on the table represents that the p-value is 
less than 0,05 which is considered a statistically meaningful difference. 
 
Figure 4.3: The comparison of the effects of Elk-1 and Elk-1-VP16 on the promoter activity. 
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5. CONCLUSION  
This study is an initial report on transcriptional regulation of the KATNB1 gene, 
representing only the tip of the iceberg. Analysis of deletion constructs showed that a 
518 bp TATA-less promoter was sufficient for high level of activity. Effects of ETS-
family members transcription factors namely, Elk-1 and PEA3 are studied. While the 
overexpression of Elk-1 transcription factor acts by repressing the promoter in a 
SUMO dependent way, in addition to some other modifications of Elk-1, PEA3 was 
not found to act on the promoter. 
This preliminary data help to understand the regulation of this important gene, but 
further confirmation studies are needed to be done. Site-directed mutagenesis of the 
mentioned factors binding site may strengthen our data. Currently the chromatin 
immunoprecipitation technique is the most precise method to identify and analyze 
transcription factor binding site. Electron mobility shift assay, super-shift assay that 
have been used extensively to study DNA-protein interactions may reveal the 
physical interaction of these transcription factors with the KATNB1 promoter. 
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APPENDICES 
APPENDIX A. Sequence Data of Constructed pGL3-Basic-Deletion Constructs 
plasmids 
▪ Sequence Data of Constructed pGL3-Basic-F1 
 
F1_For          AGGTACCTCATCTGTAAATGGGAACAGGAATTCCTACCTCTTATGGTTGTACTGGGCGTT 60 
pGL3_F1         -------TCATCTGTAAATGGGAACAGGAATTCCTACCTCTTATGGTTGTACTGGGCGTT 53 
                       ***************************************************** 
F1_For          ATGTGAGCCCAAGGAGCCCTGACCTGCGGTGAGAGGCTGGAGGCCGAAGGGCAAGGTTCG 120 
pGL3_F1         ATGTGAGCCCAAGGAGCCCTGACCTGCGGTGAGAGGCTGGAGGCCGAAGGGCAAGGTTCG 113 
                ************************************************************ 
F1_For          AGGGGCTCTGGGTGCCTGGGACAACCTCTGGGCAACAGGGAGAGGCGGCTGCGGGGCCAA 180 
pGL3_F1         AGGGGCTCTGGGTGCCTGGGACAACCTCTGGGCAACAGGGAGAGGCGGCTGCGGGGCCAA 173 
                ************************************************************ 
F1_For          GTCCCTCCTAAGCGGCCACGCGAGAGGCCCTGAGTCGAGAAGGGTTACGGCGCTTCCCAG 240 
pGL3_F1         GTCCCTCCTAAGCGGCCACGCGAGAGGCCCTGAGTCGAGAAGGGTTACGGCGCTTCCCAG 233 
                ************************************************************ 
F1_For          AGCCCACCCCGCCCAACGTGTCACAAATAAAGCTGGCCTTTCTCCGATTCCCTGATTGCA 300 
pGL3_F1         AGCCCACCCCGCCCAACGTGTCACAAATAAAGCTGGCCTTTCTCCGATTCCCTGATTGCA 293 
                ************************************************************ 
F1_For          GCCATTCAGGGAGCAGCCCCTTGCCCACGCATCCATTAGTCGAGGCGGTGGCTGCGTGTG 360 
pGL3_F1         GCCATTCAGGGAGCAGCCCCTTGCCCACGCATCCATTAGTCGAGGCGGTGGCTGCGTGTG 353 
                ************************************************************ 
F1_For          CAGTGCTACAGGGTTCAGCGCCTGCCTCGGCTCCGGAATCAGGCTGTTTCCTTCTAGACC 420 
pGL3_F1         CAGTGCTACAGGGTTCAGCGCCTGCCTCGGCTCCGGAATCAGGCTGTTTCCTTCTAGACC 413 
                ************************************************************ 
F1_For          TCCCATGGGGGATTCAAGCCGGCGTCCGGGTCAAAGAACAGGGACAAAGTCCTCCTGCCA 480 
pGL3_F1         TCCCATGGGGGATTCAAGCCGGCGTCCGGGTCAAAGAACAGGGACAAAGTCCTCCTGCCA 473 
                ************************************************************ 
F1_For          CGGGGGACCATCTGCAGGCAAAGTGAAGAATGAGGAGCTTCGGCAAAATGCCGACTAAGG 540 
pGL3_F1         CGGGGGACCATCTGCAGGCAAAGTGAAGAATGAGGAGCTTCGGCAAAATGCCGACTAAGG 533 
                ************************************************************ 
F1_For          CCTCCTTAGGTTTTGCCCCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCCGAA 600 
pGL3_F1         CCTCCTTAGGTTTTGCCCCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCCGAA 593 
                ************************************************************ 
F1_For          GTTCCTTTCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATTGGT 660 
pGL3_F1         GTTCCTTTCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATTGGT 653 
                ************************************************************ 
F1_For          CAATCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGGGCGGCTCTCAAAA 720 
pGL3_F1         CAATCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGGGCGGCTCTCAAAA 713 
                ************************************************************ 
F1_For          GTTTTCAGACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAAACTTGAGAC 780 
pGL3_F1         GTTTTCAGACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAAACTTGAGAC 773 
                ************************************************************ 
F1_For          GGAGGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGCGGCTC 838 
pGL3_F1         GGAGGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGCGGCTC 833 
                ************************************************************ 
F1_For          TTGAACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAGGAGGGCGGGTACTGAGGAAA 878 
pGL3_F1         TTGAACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAA 893 
                          ************************************************************            
F1_Rev          TTCCTTAAGACTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGC 146 
pGL3_F1         TTCCTTAAGACTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGC 899 
                ************************************************************ 
F1_Rev          AGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGCAGCTGAT 206 
pGL3_F1         AGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGCAGCTGAT 959 
                ************************************************************ 
F1_Rev          TGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTTGGC 256 
pGL3_F1         TGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGT--------- 1000 
                *****************************************          
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▪ Sequence Data of Constructed pGL3-Basic-F2 
 
F2_F            GGTACCATCTGCAGGCAAAGTGAAGAATGAGGAGCTTCGGCAAAATGCCGACTAAGGCCT 60 
F2              GGTACCATCTGCAGGCAAAGTGAAGAATGAGGAGCTTCGGCAAAATGCCGACTAAGGCCT 60 
                ************************************************************ 
F2_F            CCTTAGGTTTTGCCCCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCCGAAGTT 120 
F2              CCTTAGGTTTTGCCCCACTCCAAGATGGAAGGCCTGAGGCTTCACACTGCCCCCGAAGTT 120 
                ************************************************************ 
F2_F            CCTTTCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATTGGTCAA 180 
F2              CCTTTCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATTGGTCAA 180 
                ************************************************************ 
F2_F            TCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGGGCGGCTCTCAAAAGTT 240 
F2              TCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGGGCGGCTCTCAAAAGTT 240 
                ************************************************************ 
F2_F            TTCAGACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAAACTTGAGACGGA 300 
F2              TTCAGACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAAACTTGAGACGGA 300 
                ************************************************************ 
F2_F            GGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTG 360 
F2              GGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTG 360 
                ************************************************************ 
F2_F            AACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGC 420 
F2              AACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGC 420 
                ************************************************************ 
F2_F            GGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGCAGCT 480 
F2              GGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGCAGCT 480 
                ************************************************************ 
F2_F            GATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTTGGCATTCCGG 540 
F2              GATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTTGGCATTCCGG 540 
                ************************************************************ 
▪ Sequence Data of Constructed pGL3-Basic-F3 
                                                                    
F3_Rev          CACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAAACTTGAGACGGAGGCG 540 
pGL3_F3         CACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAAACTTGAGACGGAGGCG 59 
                ************************************************************ 
F3_Rev          GGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTGAACG 600 
pGL3_F3         GGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTGAACG 119 
                ************************************************************ 
F3_Rev          TTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGCA 660 
pGL3_F3         TTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGCA 179 
                ************************************************************ 
F3_Rev          GAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGCAGCTGATT 720 
pGL3_F3         GAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGCAGCTGATT 239 
                ************************************************************ 
F3_Rev          GGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTGGCATCCGGTAC 777 
pGL3_F3         GGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGT----------------- 279 
                **************************************** 
▪ Sequence Data of Constructed pGL3-Basic-F4 
 
F4_F            ------GGAGGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGG 43 
F4              GGTACCGGAGGCGGGACTAAGGAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGG 60 
                    ***************************************************** 
F4_F            CGGCTCTTGAACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTG 103 
F4              CGGCTCTTGAACGTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTG 120 
                ************************************************************ 
F4_F            AGGAAAAGCGGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCC 163 
F4              AGGAAAAGCGGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCC 180 
                ************************************************************ 
F4_F            GCGGCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTTG 223 
F4              GCGGCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTTG 240 
                ************************************************************ 
▪ Sequence Data of Constructed pGL3-Basic-F5 
 
F5_F            TAGGTACCTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAA 60 
F5              --GGTACCTTCCTTCCTCTTGATTAGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAA 58 
                  ********************************************************** 
F5_F            AAGCGGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGC 120 
F5              AAGCGGCAGAAGCGCCTGCTTCCATTGGTCAGTCCTGGCAGGAGGCGGAGCACCCGCGGC 118 
                ************************************************************ 
 111
F5_F            AGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTTGGCATT 180 
F5              AGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAGCCGGAGGTAAGCTTGGCATT 178 
                ************************************************************       
▪ Sequence Data of Constructed pGL3-Basic-F6 
 
L2R             CCCCAGTGCAAGTGCAGGTGCCAGAACATTTCTCTATCGATAGGTACCGGGCGGGGCTCT 540 
Long            ------------------------------------------GGTACCGGGCGGGGCTCT 18 
                                                          ****************** 
L2R             GAGCCGGAGGTAAGCTTGGCATCCGGT 567 
Long            GAGCCGGAGGTAAGCTT---------- 35 
                *****************           
▪ Sequence Data of Constructed pGL3-Basic-F7 
 
L1_Rev          AAATAGGCTGTCCCCAGTGCAAGTGCAGGTGCCTGAACATTTCTCTATCGATAGGTACCC 840 
Short           AAATAGGCTGTCCCCAGTGCAAGTGCAGGTGCCAGAACATTTCTCTATCGATAGGTACCC 695 
                ********************************* ************************** 
L1_Rev          TCTGAGCCGGAGGTAAGC-------------- 858 
Short           TCTGAGCCGGAGGTAAGCTTGGCATTCCGGTA 727 
                ******************               
 
 
APPENDIX B. Sequence Data and analysis of 4292 base pair region between 
CCDC135 and KATNB1 genes 
 
 
TTTGTGCCTTGCGCTTCACAAGCTCCAGCAGCAGCCTTTCTCTTCTTCTGTTATCTATAGCCTGGGAC
CACCCCCTTCCTCCCCTTGGCCTGTCGTTTGCTTCCTGTCCTTCTCTCCGTTGGAATGTCAGGTCTTC
ACAGCACCTCTGCAGATGGTCCCACAGCCATCTGCAAACAACTGGTTATATCTCAATGTGACTAGGGT
GGCCCACCTCACCAAGTGGGATGGGGAAGGCTAAGATGCATGCCCCAGAATTTGAGGACTGAATCCCA
GCTCCTCCTCTTACCAGATACCACTTACCCATCTGTGGAATGGGGTAGCATTGTTGCATTAAATAAGA
CTTATGGCCAGGTGTGGTGGCTCACACCTGTAATCCCAACATTTAGGGAGGCTGAGGCAGGAGGATCA
CTTGATCCCAGGAGTTTGAGACCAGCCTGGGCAACATAATAAGACCCCATCTCTAAAAAAAAAAAAAA
ACAAAGAGCCAGGCATGGTGGCATGAGCCTGTAGTCCCAGCTACTCAGGAGGCTGAGGTAGGAGGATC
ACTTTCACCTAGGAAGTCAAGGCTGCAGTGAGCCATGATTGCACCACTGCACTTCAGCCTAAGCAACA
GAGCAAAACCCTGTCTCAAAAAAAAGAAAAAAAAGACATAAATTATAAAGCAGGGAGGCTGGGAATGG
CACATAGAAAGCAGTCATTAAATGTTAGCTTACAAAATAGCCAAAAAACACATGAAATGGTTGTCAAA
TTCATGAGTCATCTGGCAAATGAAATGTCACAACACCCTCCGGTATGAAAAAAATAAAAAGTACTGGT
GACGATGAGAAACAACTGGAACTCCCAAATAGCCTTCCTAGTGAAAGTATAAATCAGTACAACCATTT
TGGAAAACTGCTTGGCATTATCTATTAAAGCTAAACTAAAGCCCAACAATTCTACTCTTAGGTTCTAC
TCCAATCCATCATTCATCAAGTAAGAATGATGAACAACTCAACCGAAATGTAGATAGATAGTTATCTG
CTAAAAGGCATGTGCTAGAACTTTCATAGCAGCATTATTGATAATAGCACCATACTTGGAAGTTACCC
AAATGCCCATCAAGAGCAGAATGGATACATAAATTGTGGTCTTCAGATATTTTGGGTTGTCTTTAACT
GCTTAGGGAGAACTGCTTAGGGAGAATGCTACTGGCATCTAGTGCATACAGGCCAGGGATGCTGCTAA
ACATTCTACAATGCCCAGAACAGCCCCCCACAGCAAATAATTATCTAGGTCTAAATGCCAATAATGTT
GAGGTTATAGAGTATATTAGTCTGTTTTCACACTGCTGATTAAGACATACTCAAGACTGGGTAATTTG
TAAAGAAAAAGAGGTTTAATGGACTCACAGTTCCACACGGCTGGGGAGGCCCCACAATCATGGCAGAA
GGCCAAAGGCACATCTTACATGGTGGCAGACAAGAAAGAATGAGAACCAAGCAAAAAGGAAAATCCCT
TATAAAATCATCAGCTCTCGTGAGACTAATTCACTACCATGAGAACAGTATGTGGGAAACCCCTCCCA
TGATTCAGTTATCTCCCACTGGGTCCCTCCCACAATATGTGGGAATTATGGGAGCTACAATTCACAAG
ATGAGATTTGGGTGGGGATACAGCCAAACCATATCATAGAGCAATGAAAATGAATGAACTGCAACACA
ACTATATGGAATGATATGGTCAAACTGCCTAAGTATAATGTCAAAAGATTCAAGACACAAAAGTACAT
ACTCTATTATTCCATTTATGGAAAGAACAAAAATAAGGAAAATTAATTGGTGATATTAGAAGTCAGGA
CAACCGTCACTCTTGGAGTGTGAGGGTTAGTGAATGGATGTGAGCATGGAGCCCTGGGAGGGGAGGTT
CTGGTTTCTAGTCACGTTCTGCTTTTTGACCTGGGTGTGTTCGGTTTGTAAAAATTCATCAACCTTGT
GCACTTACAATGTGTCCTCTGGAGTGTTTTTGACTGCTTGTTGTCATGAATCTAATCAAGCCTTTAGC
CCTAACTTAAGAAATTCAAGGGAAGAAATGCATTTAAGAAGAACGTCCATCTAACAAGAACTTCAGGA
AATTCAGGTAAATGATACTAAAAGGAAACATTCCTAACGTGGGACAATCTAGGTAAATGGCCTGATCT
CTTCAAAAGATCGATGTCATAAAAATAAAAGTTTGGGGACAGAAATGGAAAGAACTTAAGAGTCAAGT
GTGGTGAATACTGATTGGTTCTTAGTTAGAAAAAAAAAGTCCTAAAAGGTTTTTGGGATGACTGGGGA
 112
CATACGAATATGGACTGGTTGTTACAGAATTAAATTTTCTTAGCAGTGGTGATAACAATGGTTATTGT
AGAATAAGGGCTTTATTTTTATTTTTTGAAATGGATCTCACTCTGTCGCCCAGGCTGGAGTACAGTGG
CCCCATCCCAGCTCACCGCAACCTCTGCTTCCCAGTTTCAAGTGATTCTCCTGCCTCAGCCTCCCCAG
TAGCTAGGATTATAGGCACGTGCGCCACCACGCCCGGCTAATTTTTGTATTTTTTTGTAGAGACGGGG
TTTCACCATGTTGGCCAGGTTGGTCTCGGACTCCTGACCTCAGGTGATCCGCCCGCCTTGGCCTCCCA
AAGTGCTGGGATTGCAGGCGTGAGCCACCGCGCCTGGCCAAGGGCCTTATTTTTAAGAGATACATGCT
CAGTATTTGGTGTTGGGGTGAAATGTCATATCTACAATTTTCAAATGGTTCCGAAAAGACACACAGAC
GAAGCAAATATGGCAAACTGTTAACAAGTACTGGAATCTACGTGGTATCATTATATTGTCTTTTAAAG
TTTTCTCTGTTTAGTTTTCTTTTTATAATACAAAATTAAGGGGAACTGCAGGCTAGACAGTTTTGATC
CGATGTTATTCTGCTAATCTTTTAAAGGTGTCTTGCGGTGACTCACGCCTGTAATCCCAGCACTTCGG
GAGGCTGGGGCGGGTGGATCACCTAAGGTCAGGAGTTCAAGACCAGCCTGGCCAAAATGGAGAAACCC
CGTCTCTACTAAAAATATAAAAACTAGCCTTAGCCCGTCGTGGTGGCGGGCGCCTGTGGTTCCAGCTA
CCCAGGAGGCTGAAGCAGGAGAATCTGAAGCAGAAGGCTGAAGCAGAAGGCAGAGTGGGGACTCCCCC
ACGCTTTGGCTTTCAGAACAAGGGTTCGAATTCTGGGGCTATTACTTTCTGACCGTGTGGTTTTCTGC
AAGCATCTTAACCCGGGCCTCAGTTTCCTCATCTGTAAATGGGAACAGGAATTCCTACCTCTTATGGT
TGTACTGGGCGTTATGTGAGCCCAAGGAGCCCTGACCTGCGGTGAGAGGCTGGAGGCCGAAGGGCAAG
GTTCGAGGGGCTCTGGGTGCCTGGGACAACCTCTGGGCAACAGGGAGAGGCGGCTGCGGGGCCAAGTC
CCTCCTAAGCGGCCACGCGAGAGGCCCTGAGTCGAGAAGGGTTACGGCGCTTCCCAGAGCCCACCCCG
CCCAACGTGTCACAAATAAAGCTGGCCTTTCTCCGATTCCCTGATTGCAGCCATTCAGGGAGCAGCCC
CTTGCCCACGCATCCATTAGTCGAGGCGGTGGCTGCGTGTGCAGTGCTACAGGGTTCAGCGCCTGCCT
CGGCTCCGGAATCAGGCTGTTTCCTTCTAGACCTCCCATGGGGGATTCAAGCCGGCGTCCGGGTCAAA
GAACAGGGACAAAGTCCTCCTGCCACGGGGGACCATCTGCAGGCAAAGTGAAGAATGAGGAGCTTCGG
CAAAATGCCGACTAAGGCCTCCTTAGGTTTTGCCCCACTCCAAGATGGAAGGCCTGAGGCTTCACACT
GCCCCCGAAGTTCCTTTCCCATTGGCTATCTGGGAATTGAGTTTTCCAATAATGCGGACGCTGATTGG
TCAATCCAGGACGGTTGCTCAAGCCATTGGCGCAGCCGCCATTGGAGGGCGGCTCTCAAAAGTTTTCA
GACACAAATTAGGTTCGAGGGAGGAAACGGAGAGGAAAGGGAAAACTTGAGACGGAGGCGGGACTAAG
GAAACGGCAGCTTGCATTGGTTTATTAGAGGCCAAGGGGCGGCTCTTGAACGTTCCTTCCTCTTGATT
AGTCCTATTTAGGAAAAGAGGGCGGGTACTGAGGAAAAGCGGCAGAAGCGCCTGCTTCCATTGGTCAG
TCCTGGCAGGAGGCGGAGCACCCGCGGCAGCTGATTGGTGCGGGAGGCAAGGTGGGCGGGGCTCTGAG
CCGGAGGT 
 
 
 
TATAAA : TATA Box motif 
GGNCAATCT : CAAT Box motif 
GGGCGGG : CG Box motif 
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